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Abstract 
 
The oligothioetheramide (oligoTEA) family is a novel set of synthetic macromolecules with 
the advantageous characteristic of sequence-specificity. Due to their abiotic and highly modular 
nature, oligoTEAs are currently being explored in a variety of biological applications, ranging from 
use as antibacterial and antiviral agents, to use as heteromultifunctional cross-linkers and cell-
penetrating agents.  
The problem of endosomal escape in intracellular drug delivery represents an arena where 
this family of macromolecules may find potential use. Here, I report initial investigations into the 
physiochemical properties of oligoTEAs that would be relevant in tackling such a problem. 
Together, these methods and results can form the basis for future rational design of an oligoTEA 
endosomal escape agent. 
pKa and hydrophobicity are two key parameters routinely used in assessing the viability of 
new drug delivery candidates.  Due to the key role of protonation in activating the function of a 
hypothetical endosomal escape agent, a study was performed to characterize the impact of certain 
noncovalent intramolecular interactions on side-chain protonation. From partitioning data, bulk 
microscopic measurements of pKa and hydrophobicity were determined for a library consisting of 
oligoTEAs of differing length and backbone composition.  
Polyprotic oligoTEAs may differ in their ionization potential and endosomal escape potency 
compared to their monoprotic counterparts if there are significant side-chain interactions. The 
presence or absence of nanoscale intramolecular interactions between oligoTEA sidechains is 
inferred using equilibrium statistical mechanical models on the partition measurements. In doing so, 
I highlight the difficulty in using molecular topology to predict the ability of a side-chain to influence 
the protonation of neighboring side-chains. 
Rationalizing and interpreting these physiochemical properties of oligoTEAs is taken from a 
bottom-up perspective. Correlations between the parameter values of individual components and 
the parameter values of composite structures are highlighted. The data suggests that interactions 
between the side-chain and backbone interactions in the class of oligoTEA macromolecules 
explored in this work are minimal. 
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Introduction 
 
Progress of RNAi therapeutics 
It has been nearly 2 decades since the endogenous gene silencing mechanism known as RNA 
interference (RNAi)1 was demonstrated to occur in mammalian cells2.  Soon after, RNAi was shown 
to have therapeutic potential in mice3 and in humans4. Since then, considerable effort has been 
expended to translate this powerful genetic tool into targeted therapeutics. Despite several setbacks, 
research and development in this area seems to be gaining steam. As of 2017, 16 companies were 
pursuing RNAi drugs across 28 clinical trials1,2.  While there has been an estimated billions spent in 
developing RNAi therapeutic technologies6, to date, only one RNAi drug has gained FDA 
approval7,8.  While the first siRNA therapy, patisiran by Alnylam, which was approved August 2018, 
is certainly a milestone breakthrough in the area of RNA therapeutics, a number of key challenges 
remain to be addressed by the community9–12.   
Lipid nanoparticle-encapsulated and GalNAc-conjugated siRNAs are the current industry 
standard for RNAi drug delivery13. A common drawback is that both platforms almost exclusively 
target liver cells. Looking to deliver RNAi drugs to other organs necessitates exploration of next-
generation strategies. A key problem is that there is no known organ-specific ligand-receptor pair 
that both expresses at the level (in excess of 500,000 surface copies) and has the low cycling time 
(15-20 minutes) of the GalNAc-ASGPR pair on hepatocytes14–17. While it may be easy for 
hepatocyte targets to reach the estimated ~2-5,000 siRNA copies needed to elicit a RNAi response18, 
the cytosolic RNA copy number becomes a major issue when moving to targets beyond liver cells.  
Thus, it becomes a problem of either (1) finding better ligand-receptor pairs that are both abundant 
and rapidly cycling or (2) improving the efficiency of siRNA uptake and escape from the endocytic 
pathway. This work is broadly motivated by the engineering challenges presented by the latter. 
 
Barriers to siRNA delivery: endosomal escape 
Uptake across the cell membrane of exogenous double-stranded RNA (dsRNA), the key 
drug payload in RNAi therapeutics, is known to be mediated via receptor-mediated endocytosis19,20. 
Several leaders in the field make the case that controlled release of dsRNA from the endocytic 
pathway (termed endosomal escape) remains the greatest obstacle to the next generation of RNAi 
drugs21–25. Delivery vectors should be stable, low-toxicity agents that can facilitate efficient, reliable 
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escape of dsRNA cargo out of the endocytic pathway before the cargo becomes subject to lysosomal 
degradation. An apt analogy for the problem is the use of the Trojan Horse to deliver a payload of 
Greek soldiers to invade the city of Troy. Here, the payload is dsRNA that needs to make it into the 
cell without being detected, and the Horse itself is any delivery system that will allow unimpeded 
entry into the cell’s interior, with the additional caveat that the Horse must enter the cell through a 
specific entryway (the endocytic pathway). Once inside the cell, the problem of endosomal escape 
means there needs to be a mechanism to release the payload from the Horse or else the cell will just 
destroy the Horse after a certain amount of time.  
It is interesting to note that Nature has developed solutions to this problem; many bacteria 
and viruses have evolved mechanisms to facilitate endosomal escape. One famous example is the 
hemagglutainin protein found in influenza viruses26.  Reports of their possible mechanisms include 
strategies such as pore formation, the proton sponge effect, and membrane fusion22,27. But rather 
than simply extracting the specific compounds bacteria and viruses use or making similar derivatives, 
a more fruitful and scalable enterprise would be to understand the principles behind those 
mechanisms and use that inspiration to design a broader class of endosomal escape agents. For 
instance, the use of pH in some of these mechanisms as a control switch is the source of inspiration 
for the synthetic escape agent pursued in this work. 
Currently there are three broad strategies to facilitate endosomal escape: use of membrane-
destabilizing lipids, use of membrane-destabilizing peptides/polymers, and increasing endosomal 
accumulation9. The use of peptides and polymers as membrane-destabilizing agents is attractive due 
to the vast number of possible chemical modifications that can be made28–30. Synthetic polymer-
based agents typically have the additional advantage of being less susceptible to degradation. Careful 
choice of chemical modification can also prevent invoking an immune response, as demonstrated in 
a number of synthetic systems31,32. With the large selection of potential chemistries, the goal 
becomes finding a chemistry toolbox that will allow for precise engineering of an endosomal escape 
function.  
 
OligoTEA chemistry: a modular platform for engineering sequence-specific function 
Oligothioetheramides (oligoTEAs) are a novel family of sequence-defined compounds 
incorporating the efficiencies of click chemistry33. Using a unique allyl acrylamide monomer with 
two orthogonal reactive sites, sequence-specific oligomer growth using alternating thiol-Michael and 
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thiol-ene click additions can be rapidly achieved without the need for protection/deprotection 
strategies. This robust platform allows for a rich diversity of functional groups in both the allyl 
acrylamide monomer side chain and in the dithiol comonomer. Consequently, the combinatorial 
nature of their diversity offers potential for engineering sequence-specific function into 
biotechnology applications. Due to their abiotic and highly modular nature, oligoTEAs are currently 
being explored in a variety of biological settings, ranging from use as antibacterial34,35 and antiviral 
agents, to use as heteromultifunctional cross-linkers36 and cell-penetrating agents.  
As the previous sections suggest, one other arena where this family of compounds may find 
potential use is the problem of endosomal escape in intracellular drug delivery. Broadly speaking, the 
pharmaceutical industry is approximately a $1 trillion global market, which would easily explain why 
there is an enormous literature of innovation on the issue of drug delivery (IMS Institute for 
Healthcare Information. Global Outlook for Medicines Through 2018, 2014). In the domain of 
intracellular delivery, such as in the systemic delivery of RNA, while the amount of effort has been 
extensive, few satisfying solutions have made it through the clinical process37. OligoTEAs may be a 
versatile ingredient in addressing this problem as they may be used in several ways: (1) complexing 
the oligoTEA to a drug to make a formulation, (2) using the oligoTEA in a liposome system, or (3) 
conjugating the oligoTEA directly to the drug. 
For promising young technologies such as the CRISPR-Cas9 system, the question of delivery 
is still in an infantile stage of exploration38. While the focus of this work was done with applications 
for siRNA delivery in mind, the problem of endosomal escape is a generic one for intracellular 
delivery. I present here initial investigations in using oligoTEAs as a platform for tackling endosomal 
escape. Together, these methods and results can be taken as part of a basis for future rational design 
of an oligoTEA endosomal escape agent. 
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Part 1. Designing an oligoTEA library to test noncovalent intramolecular interactions 
 
Key Design Parameters: pKa and hydrophobicity 
The acidity of endosomal compartments has been observed to be highly dynamic, decreasing 
from a physiological pH of ~7.4 to a  pH of ~5 on the order of minutes after endosome 
formation39. Some delivery strategies seek to exploit this endosomal maturation to mask the system’s 
presence in the endocytic pathway until the endosome reaches a pH threshold. Subsequent 
acidification of the endosomal compartment triggers a change (typically conformational) in the 
system, activating its endosomal escape function. The acid dissociation constant, known commonly 
as the pKa, reflects the lability of a compound to be protonated, making it a natural parameter to 
tune to respond to the endosome environment. Studies show the pKa of a membrane-destabilizing 
compound can be a critical parameter in delivery efficacy40–42.  This suggests kinetic and spatial 
control of the protonation reaction in this pH window as a potentially important design 
consideration for endosomal escape agents. 
The hydrophobicity is another key parameter to consider in designing a potential escape 
agent. Lipophilicity, a term often associated with hydrophobicity, has long been known to be 
implicated in drug properties such as adsorption, distribution, metabolism, elimination, and 
toxicology43. From a physical standpoint, escaping the endosome necessitates an intimate interaction 
with a lipid membrane44. The hydrophobicity of an agent can serve as a potential proxy for 
predicting that membrane interaction. From a synthesis standpoint, the challenge lies in 
understanding how the overall hydrophobicity emerges from the different chemical components of 
the agent.  
If one imagines a pKa and hydrophobicity parameter space that contains every possible 
oligoTEA sequence, one would of course want to pick parameters that ultimately lead to optimal 
escape of the payload. The problem is that both (1) the values of these optimal parameters are 
unknown and (2) it is not immediately clear how parameter values change as you make modifications 
to the oligoTEA components. 
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Exploring oligoTEA noncovalent intramolecular interactions 
Quantifying the effect of noncovalent intramolecular interactions between components of 
an oligoTEA should provide an initial thrust for more rational movement in this design space. The 
interactions, especially if charged groups are involved, will help dictate the oligoTEA’s conformation 
and dynamics in solution. This is critical because how the ionized side chains are presented to other 
molecules in solution will dictate the nature of that interaction. While the mechanism of the 
membrane-destabilizing interaction believed to occur during endosomal escape is not well 
characterized30, the conformation of the oligoTEA and the charges it presents will affect the 
intermolecular interactions with the endosomal membrane45. Thus, understanding noncovalent 
interactions would also aide in the prediction of intermolecular interactions between the escape 
agent and endosomal membrane. Due to the key role of protonation in activating the escape 
function, two logical subsets of intramolecular interactions to study are the effects of neighboring 
side-chains and backbone groups on the protonation of an oligoTEA side-chain.  
 
Interactions between two side-chains groups 
Polyprotic compounds may differ in their endosomal escape potency compared to their 
monoprotic counterparts if there are significant side-chain interactions. Here, I begin to address how 
molecular topology might influence the protonation of neighboring side-chains. A cation can be 
generated by choosing a side-chain group (such as a tertiary amine) that can be protonated at pH’s 
resembling an endosome. The sequence of an oligoTEA can thought of as a molecular topology that 
gives a connectivity distance between side-chain groups. By using different backbone comonomers, 
one can purposely modulate the topological distance between neighboring side-chains. Thus, one 
question we would like to answer is what effect does the molecular connectivity have on electrostatic 
interactions, and how does that in turn affect the molecule’s pKa? 
 
Interactions between the backbone and a side-chain group 
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How is the ionization of an ionized side-chain group affected by the hydrophobicity of the 
backbone group? A recent study suggests charge and hydrophobicity are closely linked46, which 
suggests that the composition and hydrophobicity of the backbone should affect the electrostatic 
environment surrounding the side-chain moiety.  Depending on how the backbone perturbs the 
local environment, this could cause slightly different molecular conformations, which in principle 
could affect the likelihood for the side-chain group to be protonated. If true, by varying the choice 
of backbone group, I would have an additional handle to be able to move in the oligoTEA pKa and 
hydrophobicity space. 
 
Through varying the mer length and molecular topology, one can presumably modulate the 
interaction between side-chains. By choice of backbone group, one influences the interaction 
between a side-chain group and the oligoTEA backbone. Therefore, I chose a library consisting of 
1-, 2-, and 3- mers to observe interactions between side-chains. The 1- mer was used as a negative 
control since there is no side-chain interaction possible in that compound. There were 3 different 
dithiol backbone comonomers, each of a different hydrophobicity: a hydrophobic comonomer 
(propanedithiol), a hydrophilic comonomer (D/L-dithiothreitol), and an amphiphatic comonomer 
(2,2’-(Ethylenedioxy)diethanethiol). The resulting 3x3 library can be visualized as follows.  
 
 
Dithiol comonomer Relative Hydrophobicity 
Propanedithiol (PDT) Hydrophobic 
D/L-Dithiothreitol (DTT) Hydrophilic 
2,2′ -(Ethylenedioxy)diethanethiol (PEG2) Amphiphatic 
11 
 
 
 The oligoTEA library was synthesized using protocols adopted from Porel et. al33, purified 
using RP-HPLC, and characterized with both LC-MS and NMR. The protocols are outlined in the 
Materials and Methods section and the relevant spectra are given in the Compound Verification 
section (Supplementary Info). 
  
3-mer 
2-mer 
1-mer 
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Part 2. Parameter analysis at bulk microscopic resolution from partition measurements 
 
Shake flask method for log D measurements 
 For measuring the hydrophobicity and pKa of a compound, there is a convenient experiment 
to get at both parameters simultaneously. Termed the shake flask method, this experiment measures 
the equilibrium partitioning of a compound between two immiscible phases (ex. octanol and water). 
Due to synthesis scale constraints, the measurements require high sensitivity. Using a highly sensitive 
and high-resolution technique such as LC-MS, one can accurately quantify concentrations as low as 
~100 ng/mL in each phase. The relative distribution of compound between the two phases is 
termed the distribution coefficient (abbreviated D and generally reported in the literature in log 
form, hence log D measurements). A schematic of the methodology is given below.  
By repeating the experiments in aqueous solutions of different pH, one can correlate the molecule’s 
ionization profile with its hydrophobicity. From that profile, one can extract out parameters such as 
pKa and different aspects of hydrophobicity. The measurement is considered a bulk measurement 
because only the total concentration of all ionization species in a phase is measured (rather than the 
concentration of each individual ionization species if there are multiple ionization states, ex. the 
multi-mers may have multiple ionization states). 
 Since the D parameter is an equilibrium thermodynamic parameter, it can also be thought of 
as the equilibrium constant associated with the free energy transfer of a compound into the octanol 
phase from the aqueous phase. Compound	(𝑎𝑞𝑢𝑒𝑜𝑢𝑠)	←→	Compound	(𝑜𝑐𝑡𝑎𝑛𝑜𝑙)												∆G° = RTlnD 
Only recently has the log D parameter been used as a useful measure of hydrophobicity for peptide-
mimetics. Bolt et. al showed that hydrophobicity quantified through log D can be more reflective of 
the proper folded state of a compound than hydrophobicity quantified through HPLC-retention 
time47. Quantifying hydrophobicity from reverse-phase HPLC retention times offers different 
information because those runs are generally done at highly acidic conditions (pH <2), which would 
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not properly reflect conditions seen in a biological setting. Whereas in a partition experiment, the 
choice of the contents of each phase can be arbitrarily chosen. These experiments are the first log D 
measurements on the oligoTEA class of compounds.  
 Shown below is a log D vs. pH plot characteristic of the data obtained from a shake flask 
experiment. The curves on these plots can be naturally fit with a sigmoidal function with 4 
independent parameters: pKa, Hill slope, log Dmax, and log Dmin. The pKa occurs at the inflection 
point in the sigmoid, which is physically interpreted as the concentration of protons in solution (i.e. 
the pH) where the number of neutral species is equal to the number of ionized species. The Hill 
slope is the linear slope of the sigmoid at the inflection point; remembering that log D can be 
defined in terms of the free energy difference to transfer the compound between the two phases, the 
Hill slope can be thought as physically corresponding to the greatest possible free energy difference 
for transferring the compound between the two phases across all pH conditions. log Dmax, and log 
Dmin correspond to the lower and upper plateau values of the sigmoid respectively. Physically, log 
Dmin is the distribution of the compound into the two phases, where all the molecules of the 
compound are in the maximally ionized state. While conversely, log Dmax is where all the molecules 
of the compound are in the neutral state. A fifth parameter, the span of log D, can be defined as the 
difference between the log Dmax and log Dmin. 
 
 
 
  
Characterizing the side chain: a reference point 
 In all members of the library, the only location where protonation can occur is on the N,N-
dimethylethylamine subunit, referred to henceforth as the tertiary amine, of the allyl acrylamide 
monomer. If one considers an entire oligomer as a string of individual allyl acrylamide and 
comonomer components, then the global features of the entire oligomer should emerge from 
pH
lo
g
 D
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knowledge of the individual components (i.e. the sequence-to-structure-to-function paradigm). I 
characterized the pKa and hydrophobicity of the monomer and its side chain to serve as a baseline 
reference. The ideal case would have been to characterize N,N-dimethylethylamine for the side 
chain, but its high volatility (a boiling point of 37 ᵒC) made it difficult to handle experimentally. 
Instead, an alcohol variant (N,N-dimethylethanolamine) was used as a proxy. 
 
 
 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
Tertiary amine monomer 6.35±0.09 0.64±0.07 -0.13±0.03 -1.77±0.04 1.65±0.05 
N,N-dimethylaminoethanol 8.19±0.09 1.43±0.47 -0.11±0.08 -1.48±0.04 1.37±0.09 
      
In contrast with aliphatic tertiary amine compounds48 which typically have a pKa of ~10, it is 
interesting to note that the pKa of the tertiary amine monomer (T) is around 6.35. Fortunately for 
applications in endosomal escape, this pKa happens to fall within the pH maturation window of the 
endosome, pH 5 to pH 7.4.  
Both the subunit and the full monomer have nearly the same log Dmax (which is also referred 
to as the log P) when they are both uncharged. The drastically different pKa’s of 6.4 versus 8.2 
3 6 9 1 2
-2 .0
-1 .5
-1 .0
-0 .5
0 .0
0 .5
p H
lo
g
 D T e rt ia ry  A m in e  M o n o m e r
N ,N -d im e th y la m in o e th a n o l
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suggest that the local environment surrounding the tertiary amine may have a significant impact on 
its ability to be protonated. Evidence that local hydrophobicity can effect pKa has previously been 
seen in amino lipid studies41. Zhang et. al observed that a more hydrophobic environment generally 
leads to lower pKa values than expected from an isolated moiety. Recent force microscopy studies 
have also shown that increasing charge can increase local hydrophobicity46,49. 
 
Characterizing the library 
 
With knowledge of the pKa of the monomer as a reference, I then looked at the pKa and 
hydrophobicities of a library of oligomers. The following shows the log D curves for all 9 members 
of the library as a function of pH. An aggregate plot of all members is included, and plots with 
subsets of the library are shown for clarity. I make note of qualitative trends and correlations seen in 
the data but leave aside speculation to their explanations for now. 
 
 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
PEG2-T (1mer) 6.82±0.08 0.64±0.06 0.59±0.04 -1.76±0.04 2.34±0.06 
PEG2-T (2mer) 7.61±0.04 1.33±0.13 0.61±0.04 -1.92±0.03 2.53±0.05 
PEG2-T (3mer) 7.85±0.13 0.72±0.13 1.20±0.19 -3.13±0.12 4.33±0.24 
PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
PDT-T (2mer) 6.80±0.06 0.64±0.05 1.88±0.08 -2.72±0.07 4.60±0.11 
PDT-T (3mer) 7.18±0.01 1.55±0.12 2.06±0.02 -2.03±0.01 4.08±0.02 
DTT-T (1mer) 7.02±0.05 0.73±0.05 0.02±0.03 -2.43±0.03 2.45±0.05 
3 6 9 12
-4
-2
0
2
lo
g
 D
P e g -T  (1 m e r)
P e g -T  (2 m e r)
P D T -T  (1 m e r)
D T T -T  (1 m e r)
pH P D T -T  (2 m e r)
D T T -T  (2 m e r)
P D T -T  (3 m e r)
D T T -T  (3 m e r)
P e g -T  (3 m e r)
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DTT-T (2mer) 8.08±0.04 1.22±0.09 -0.20±0.03 -2.05±0.01 1.85±0.03 
DTT-T (3mer) 7.69±0.23 0.76±0.25 0.46±0.19 -2.09±0.13 2.54±0.24 
 
The pKa’s fall within the range of 6.8-8.1. Thus, in all cases, the apparent pKa of the compound was 
greater than the pKa of the individual tertiary amine monomer. Even if the compound has multiple 
charges, it is important to note that these measurements give a pKa, average. Even though each side 
chain component is identical, in principle the compound might have a unique pKa for each multiple 
of charge. This single effective pKa, average is due to the nature of the measurements. While there may 
be multiple species of different ionization states during the measurement at each pH condition, only 
an ensemble measurement over the partitioning of all species can be made.  
  
 
By mer length 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
PEG2-T (1mer) 6.82±0.08 0.64±0.06 0.59±0.04 -1.76±0.04 2.34±0.06 
PEG2-T (2mer) 7.61±0.04 1.33±0.13 0.61±0.04 -1.92±0.03 2.53±0.05 
PEG2-T (3mer) 7.85±0.13 0.72±0.13 1.20±0.19 -3.13±0.12 4.33±0.24 
 
There are a couple straightforward correlations with the PEG2 family of compounds. The pKa goes 
up, log P increases, log Dmin decreases, and the span of log D increases with increasing mer length. 
In particular, the increase in length from 2- to 3- mer greatly enlarges the hydrophobicity profile. 
3 6 9 12
-4
-2
0
2
lo
g
 D
P E G 2 -T  (1 m e r)
P E G 2 -T  (2 m e r)
pH P E G 2 -T  (3 m e r)
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Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
DTT-T (1mer) 7.02±0.05 0.73±0.05 0.02±0.03 -2.43±0.03 2.45±0.05 
DTT-T (2mer) 8.08±0.04 1.22±0.09 -0.20±0.03 -2.05±0.01 1.85±0.03 
DTT-T (3mer) 7.69±0.23 0.76±0.25 0.46±0.19 -2.09±0.13 2.54±0.24 
 
 The DTT family seems to have no glaring correlations. Qualitatively, the three profiles 
appear to be fairly superimposable.  
 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
PDT-T (2mer) 6.80±0.06 0.64±0.05 1.88±0.08 -2.72±0.07 4.60±0.11 
PDT-T (3mer) 7.18±0.01 1.55±0.12 2.06±0.02 -2.03±0.01 4.08±0.02 
 
3 6 9 12
-4
-2
0
2
lo
g
 D
D T T -T  (1 m e r)
pH
D T T -T  (2 m e r)
D T T -T  (3 m e r)
3 6 9 12
-4
-2
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2
lo
g
 D
P D T -T  (1 m e r)
pH P D T -T  (2 m e r)
P D T -T  (3 m e r)
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 For the PDT family, it seems the span of hydrophobicity of multiple mers is substantially 
increased from the single mer. There’s an increase in Hill slope and log P with mer length, but the 
pKa of all three are fairly close. 
 
By dithiol backbone comonomer 
 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
PEG2-T (1mer) 6.82±0.08 0.64±0.06 0.59±0.04 -1.76±0.04 2.34±0.06 
DTT-T (1mer) 7.02±0.05 0.73±0.05 0.02±0.03 -2.43±0.03 2.45±0.05 
 
 Perhaps not surprisingly, the relative hydrophobicity of the overall compound mirrors the 
relative hydrophobicity of the constituent backbone comonomer. Meaning, the oligomer with a 
PDT backbone was the most hydrophobic (greatest log P and log Dmin). The oligomer with the DTT 
backbone with the most hydrophilic (lowest log P and log Dmin). And the oligomer with the 
amphipathic PEG2 backbone was in between. The pKa’s are close enough that all 3 should be 
protonated with similar kinetic profiles in an endosome. It’s as if one could just translate one profile 
vertically to get one of the other two profiles. At least for the 1-mers, it suggests the possibility to 
decouple pKa and hydrophobicity with regards to backbone choice because the backbone has a 
significant effect on global hydrophobicity but a minimal one on pKa. In addition, increasing the 
hydrophobicity of the backbone caused a decrease in the Hill slope. 
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Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
PDT-T (2mer) 6.80±0.06 0.64±0.05 1.88±0.08 -2.72±0.07 4.60±0.11 
PEG2-T (2mer) 7.61±0.04 1.33±0.13 0.61±0.04 -1.92±0.03 2.53±0.05 
DTT-T (2mer) 8.08±0.04 1.22±0.09 -0.20±0.03 -2.05±0.01 1.85±0.03 
 
 As similarly seen in the 1-mers, increasing backbone hydrophobicity again increased the log 
P. However, with the addition of a 2nd mer, some new correlations arise. Increasing the 
hydrophobicity of the backbone resulted in decreasing the pKa and increasing the span of log D. 
 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
PDT-T (3mer) 7.18±0.01 1.55±0.12 2.06±0.02 -2.03±0.01 4.08±0.02 
PEG2-T (3mer) 7.85±0.13 0.72±0.13 1.20±0.19 -3.13±0.12 4.33±0.24 
DTT-T (3mer) 7.69±0.23 0.76±0.25 0.46±0.19 -2.09±0.13 2.54±0.24 
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 The family of 3-mers all show pKa, average that fall near or above physiological pH (i.e. 7.4), 
meaning all three will have some proportion of compound that is already ionized at physiological 
pH. The 3-mers also seem to have a larger span of log D than their 1- and 2- mer counterparts. For 
the 3-mers, increasing backbone hydrophobicity results in increasing log P, which is the same trend 
as the 1- and 2- mers. 
 
 
Characterization of additional modifications on the library 
 In addition to the original library, there were additional experiments done that looked at 
library members with additional modifications. 
 
End Capping 
 All members of the original library were capped with an acetyl group on the terminal primary 
amine (see left terminal of the first chemical structure shown below). A variant of the PDT-T (1mer) 
was made where the primary amine was instead capped with a benzoyl group. 
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Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
Benzoyl-PDT-T (1mer) 7.17±0.32 0.71±0.34 1.80±0.15 0.11±0.13 1.69±0.21 
Acetyl-PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
 
It is interesting to note that they have nearly identical pKa’s but very different 
hydrophobicity profiles. This suggests two things. One, the local environment of the tertiary amine 
is far enough from the cap group topologically to be insensitive to the identity of the cap, which 
would explain why the pKa doesn’t change. Two, from a design perspective this comparison 
suggests it could be possible to modify hydrophobicity independently of the pKa parameter based on 
the terminal conjugation. 
 
Half mers 
 In the original library, the addition of another dithiol comonomer was coupled to adding an 
additional possible charge to the oligomer (by only increasing the oligomer by integer mer units). 
Since one aspect of the study was to study how the backbone affects the local environment of the 
side chain, I made variants of some 1 mers. I added an additional 0.5 mer to see what the effect of 
an additional backbone unit would do.  
 
Due to the reactive nature of a free thiol, the terminal thiol of the additional dithiol 
comonomer is capped with an acetyl group. These two variants, diacetyl-PDT-T (1.5mer) and 
diacetyl-PEG2-T (1.5mer) are shown below. 
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Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
Diacetyl-PDT-T (1.5mer) 7.48±0.67 0.32±0.12 3.15±0.68 -0.10±0.21 3.25±0.81 
Diacetyl-PEG2-T (1.5mer) 7.12±0.08 0.54±0.05 1.29±0.07 -1.07±0.03 2.36±0.08 
 
 
An additional variant of the PDT is made where a monothiol was added instead of the dithiol (thus 
a second cap is not necessary). This variant, acetyl-PDT-T (1.5mer), is shown below. 
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Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
Acetyl-PDT-T (1.5mer) 6.90±0.08 0.84±0.10 1.93±0.05 -0.04±0.04 1.96±0.07 
Diacetyl-PDT-T (1.5mer) 7.48±0.67 0.32±0.12 3.15±0.68 -0.10±0.21 3.25±0.81 
 
The two variants of the PDT-T 1.5mer have fairly similar pKa, but the diacetyl variant has a broader 
log D profile, as given by the span of log D. 
 
These variants can be plotted in the context of the adjacent integer mers in the synthesis to see what 
the addition of an additional half mer does. 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
Acetyl-PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
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Acetyl-PDT-T (1.5mer) 6.90±0.08 0.84±0.10 1.93±0.05 -0.04±0.04 1.96±0.07 
Acetyl-PDT-T (2mer) 6.80±0.06 0.64±0.05 1.88±0.08 -2.72±0.07 4.60±0.11 
Diacetyl-PDT-T (1.5mer) 7.48±0.67 0.32±0.12 3.15±0.68 -0.10±0.21 3.25±0.81 
 
For the single acetyl oligomers, increasing mer length caused a slight reduction in pKa, but generally 
the pKa for the 1.5 mers still fell within a similar range to the integer mers. The addition of another 
backbone group significantly increased the log Dmin in both the 1.5 mers. And log P is significantly 
increased for the diacetyl case. With the addition of the second tertiary amine monomer, the 
hydrophobicity is significantly reduced at low pH.  
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
Acetyl-PEG2-T (1mer) 6.82±0.08 0.64±0.06 0.59±0.04 -1.76±0.04 2.34±0.06 
Diacetyl-PEG2-T (1.5mer) 7.12±0.08 0.54±0.05 1.29±0.07 -1.07±0.03 2.36±0.08 
Acetyl-PEG2-T (2mer) 7.61±0.04 1.33±0.13 0.61±0.04 -1.92±0.03 2.53±0.05 
 
The addition of diacetyl PEG2 backbone group leaves a curve with roughly the same span, except 
shifted in the hydrophobic direction. Both the log P and log Dmin parameters were increased for the 
1.5 mer. So in both the PDT and PEG2 family, the diacetyl addition results in a more hydrophobic 
log Dmin. With both the PEG2 and PDT families, at low values of pH the hydrophobicity of the 
molecules decreased going from the 1-mer to the 1.5-mer, but then the hydrophobicity was rescued 
going from the 1.5-mer to the 2-mer. This perhaps hints that the terminal component plays a key 
role in solubility when the molecule is charged: namely that ending in a dithiol comonomer results in 
a more hydrophobic compound than molecules terminating with a tertiary amine monomer. 
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Comparison of parameters across all compounds 
For each parameter, all compounds that have been tested were sorted in ascending order by 
parameter to see if there are any discernible trends. The results were ranked in a table so that the 
other parameters could be compared as well. A heatmap for each parameter is given so that 
potential clustering and outliers can be qualitatively visualized. 
 
 
pKa 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
Tertiary amine monomer 6.35±0.09 0.64±0.07 -0.13±0.03 -1.77±0.04 1.65±0.05 
PDT-T (2mer) 6.80±0.06 0.64±0.05 1.88±0.08 -2.72±0.07 4.60±0.11 
PEG2-T (1mer) 6.82±0.08 0.64±0.06 0.59±0.04 -1.76±0.04 2.34±0.06 
Acetyl-PDT-T (1.5mer) 6.90±0.08 0.84±0.10 1.93±0.05 -0.04±0.04 1.96±0.07 
DTT-T (1mer) 7.02±0.05 0.73±0.05 0.02±0.03 -2.43±0.03 2.45±0.05 
Diacetyl-PEG2-T (1.5mer) 7.12±0.08 0.54±0.05 1.29±0.07 -1.07±0.03 2.36±0.08 
Benzoyl-PDT-T (1mer) 7.17±0.32 0.71±0.34 1.80±0.15 0.11±0.13 1.69±0.21 
PDT-T (3mer) 7.18±0.01 1.55±0.12 2.06±0.02 -2.03±0.01 4.08±0.02 
PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
Diacetyl-PDT-T (1.5mer) 7.48±0.67 0.32±0.12 3.15±0.68 -0.10±0.21 3.25±0.81 
PEG2-T (2mer) 7.61±0.04 1.33±0.13 0.61±0.04 -1.92±0.03 2.53±0.05 
DTT-T (3mer) 7.69±0.23 0.76±0.25 0.46±0.19 -2.09±0.13 2.54±0.24 
PEG2-T (3mer) 7.85±0.13 0.72±0.13 1.20±0.19 -3.13±0.12 4.33±0.24 
DTT-T (2mer) 8.08±0.04 1.22±0.09 -0.20±0.03 -2.05±0.01 1.85±0.03 
N,N-dimethylaminoethanol 8.19±0.09 1.43±0.47 -0.11±0.08 -1.48±0.04 1.37±0.09 
pH
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It is interesting to see from the heatmap that the tertiary amine monomer stands out as having a 
significantly lower pKa than the rest of the library. It is also interesting that every oligomer has a pKa 
in between the monomer and its subunit proxy (N,N-dimethylaminoethanol). Nearly all the 
compounds containing PDT are clustered fairly close (from 6.8 to 7.18). As seen in the regression 
plot below, there is a weak positive qualitative correlation of the pKa parameter with the Hill slope 
parameter (R2=0.22). Regressions for all pairs of parameters (plus an additional parameter, the 
molecular mass) are found in the 2-D Regression Plots between Parameters section (Supplementary 
Information). 
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Hill slope 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
Diacetyl-PDT-T (1.5mer) 7.48±0.67 0.32±0.12 3.15±0.68 -0.10±0.21 3.25±0.81 
PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
Diacetyl-PEG2-T (1.5mer) 7.12±0.08 0.54±0.05 1.29±0.07 -1.07±0.03 2.36±0.08 
PDT-T (2mer) 6.80±0.06 0.64±0.05 1.88±0.08 -2.72±0.07 4.60±0.11 
PEG2-T (1mer) 6.82±0.08 0.64±0.06 0.59±0.04 -1.76±0.04 2.34±0.06 
Tertiary amine monomer 6.35±0.09 0.64±0.07 -0.13±0.03 -1.77±0.04 1.65±0.05 
Benzoyl-PDT-T (1mer) 7.17±0.32 0.71±0.34 1.80±0.15 0.11±0.13 1.69±0.21 
PEG2-T (3mer) 7.85±0.13 0.72±0.13 1.20±0.19 -3.13±0.12 4.33±0.24 
DTT-T (1mer) 7.02±0.05 0.73±0.05 0.02±0.03 -2.43±0.03 2.45±0.05 
DTT-T (3mer) 7.69±0.23 0.76±0.25 0.46±0.19 -2.09±0.13 2.54±0.24 
Acetyl-PDT-T (1.5mer) 6.90±0.08 0.84±0.10 1.93±0.05 -0.04±0.04 1.96±0.07 
DTT-T (2mer) 8.08±0.04 1.22±0.09 -0.20±0.03 -2.05±0.01 1.85±0.03 
PEG2-T (2mer) 7.61±0.04 1.33±0.13 0.61±0.04 -1.92±0.03 2.53±0.05 
N,N-dimethylaminoethanol 8.19±0.09 1.43±0.47 -0.11±0.08 -1.48±0.04 1.37±0.09 
PDT-T (3mer) 7.18±0.01 1.55±0.12 2.06±0.02 -2.03±0.01 4.08±0.02 
 
pH
lo
g
 D
0 .3 2
0 .5 2
0 .5 4
0 .6 4
0 .6 4
0 .6 4
0 .7 1
0 .7 2
0 .7 3
0 .7 6
0 .8 4
1 .2 2
1 .3 3
1 .4 3
1 .5 5
D ia c e tyl-P D T -T  (1 .5 m e r )
P D T -T  (1 m e r )
D ia c e tyl-P E G 2 -T  (1 .5 m e r )
P D T -T  (2 m e r )
P E G 2 -T  (1 m e r )
T e r t ia r y a m in e  m o n o m e r
B e n z o yl-P D T -T  (1 m e r )
P E G 2 -T  (3 m e r )
D T T -T  (1 m e r )
D T T -T  (3 m e r )
Ac e tyl-P D T -T  (1 .5 m e r )
D T T -T  (2 m e r )
P E G 2 -T  (2 m e r )
N ,N -d im e th yla m in o e th a n o l
P D T -T  (3 m e r )
H ill S lo p e
0 .5
1 .0
1 .5 5 3 9 .2 3
3 8 9 .2 2
6 8 7 .3 1
6 7 9 .3 7
4 2 1 .2 4
4 5 1 .2 3
1 1 4 9 .6 1
3 9 3 .2 1
1 0 6 5 .5 2
4 6 5 .2 5
7 2 9 .3 7
7 8 5 .4 3
9 6 9 .5 1
D ia c e tyl-P D T -T  (1 .5 m e r )
P D T -T  (1 m e r )
D ia c e tyl-P E G 2 -T  (1 .5 m e r )
P D T -T  (2 m e r )
P E G 2 -T  (1 m e r )
B e n z o yl-P D T -T  (1 m e r )
P E G 2 -T  (3 m e r )
D T T -T  (1 m e r )
D T T -T  (3 m e r )
Ac e tyl-P D T -T  (1 .5 m e r )
D T T -T  (2 m e r )
P E G 2 -T  (2 m e r )
P D T -T  (3 m e r )
M o le c u la r  M a s s  (a m u )
400
600
800
1000
28 
 
The heatmap indicates there are two primary populations for the Hill slope: one that contains slopes 
from 0.52 to 0.84 and another that contains slopes from 1.22 to 1.55. Within these two populations 
though, it is not quite clear if there are any trends in terms of sequence. There is a weak correlation 
between Hill slope and molecular mass (R2 = 0.18). The molecular mass heatmap is included for 
comparison (mass of monomer and its subunit excluded for more resolution on scale).  
 
 
log Dmax (log P)  
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
DTT-T (2mer) 8.08±0.04 1.22±0.09 -0.20±0.03 -2.05±0.01 1.85±0.03 
Tertiary amine monomer 6.35±0.09 0.64±0.07 -0.13±0.03 -1.77±0.04 1.65±0.05 
N,N-dimethylaminoethanol 8.19±0.09 1.43±0.47 -0.11±0.08 -1.48±0.04 1.37±0.09 
DTT-T (1mer) 7.02±0.05 0.73±0.05 0.02±0.03 -2.43±0.03 2.45±0.05 
DTT-T (3mer) 7.69±0.23 0.76±0.25 0.46±0.19 -2.09±0.13 2.54±0.24 
PEG2-T (1mer) 6.82±0.08 0.64±0.06 0.59±0.04 -1.76±0.04 2.34±0.06 
PEG2-T (2mer) 7.61±0.04 1.33±0.13 0.61±0.04 -1.92±0.03 2.53±0.05 
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PEG2-T (3mer) 7.85±0.13 0.72±0.13 1.20±0.19 -3.13±0.12 4.33±0.24 
Diacetyl-PEG2-T (1.5mer) 7.12±0.08 0.54±0.05 1.29±0.07 -1.07±0.03 2.36±0.08 
PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
Benzoyl-PDT-T (1mer) 7.17±0.32 0.71±0.34 1.80±0.15 0.11±0.13 1.69±0.21 
PDT-T (2mer) 6.80±0.06 0.64±0.05 1.88±0.08 -2.72±0.07 4.60±0.11 
Acetyl-PDT-T (1.5mer) 6.90±0.08 0.84±0.10 1.93±0.05 -0.04±0.04 1.96±0.07 
PDT-T (3mer) 7.18±0.01 1.55±0.12 2.06±0.02 -2.03±0.01 4.08±0.02 
Diacetyl-PDT-T (1.5mer) 7.48±0.67 0.32±0.12 3.15±0.68 -0.10±0.21 3.25±0.81 
 
The log P values are nicely segregated based on backbone choice. DTT-containing compounds, the 
monomer, and the monomer subunit all have the lowest log P values (all hovering around 0 with the 
except of the DTT-T (3mer)). PEG2-containing compounds occupy a space slightly higher in log P 
values. And the PDT-containing compounds have the highest log P values (clustering around 1.5-2). 
Based on the relative hydrophobicities of these dithiols, the trends are expected. For the case of 
PEG2 and PDT compounds, increasing mer length also resulted in increased log P. The Diacetyl-
PDT-T (1.5mer) also seems like an outlier based on the heatmap (with a log P greater than 1 unit 
over the next highest compound). There is also a small positive correlation of this parameter with 
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the two other hydrophobicity parameters: log Dmin (R2 = 0.23) and Span of log D (R2 = 0.28).
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log Dmin 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
PEG2-T (3mer) 7.85±0.13 0.72±0.13 1.20±0.19 -3.13±0.12 4.33±0.24 
PDT-T (2mer) 6.80±0.06 0.64±0.05 1.88±0.08 -2.72±0.07 4.60±0.11 
DTT-T (1mer) 7.02±0.05 0.73±0.05 0.02±0.03 -2.43±0.03 2.45±0.05 
DTT-T (3mer) 7.69±0.23 0.76±0.25 0.46±0.19 -2.09±0.13 2.54±0.24 
DTT-T (2mer) 8.08±0.04 1.22±0.09 -0.20±0.03 -2.05±0.01 1.85±0.03 
PDT-T (3mer) 7.18±0.01 1.55±0.12 2.06±0.02 -2.03±0.01 4.08±0.02 
PEG2-T (2mer) 7.61±0.04 1.33±0.13 0.61±0.04 -1.92±0.03 2.53±0.05 
Tertiary amine monomer 6.35±0.09 0.64±0.07 -0.13±0.03 -1.77±0.04 1.65±0.05 
PEG2-T (1mer) 6.82±0.08 0.64±0.06 0.59±0.04 -1.76±0.04 2.34±0.06 
N,N-dimethylaminoethanol 8.19±0.09 1.43±0.47 -0.11±0.08 -1.48±0.04 1.37±0.09 
PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
Diacetyl-PEG2-T (1.5mer) 7.12±0.08 0.54±0.05 1.29±0.07 -1.07±0.03 2.36±0.08 
Diacetyl-PDT-T (1.5mer) 7.48±0.67 0.32±0.12 3.15±0.68 -0.10±0.21 3.25±0.81 
Acetyl-PDT-T (1.5mer) 6.90±0.08 0.84±0.10 1.93±0.05 -0.04±0.04 1.96±0.07 
Benzoyl-PDT-T (1mer) 7.17±0.32 0.71±0.34 1.80±0.15 0.11±0.13 1.69±0.21 
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For most of the compounds, the log Dmin parameter is segregated in a fashion similar to the log P 
values. The DTT-containing compounds are clustered from -2.43 to -2.05. The 1- and 2-mer of the 
PEG2 fall in the middle of the heat map. The majority of the compounds fall within the middle 
third of the heat map (-1 to -2). Surprisingly, the 3-mer of the PEG2 is an outlier from the other 
PEG2-containing compounds, with the smallest log Dmin in the library. The variants of the PDT-T 
are outliers on the other end of the spectrum, clustering around 0. There is a weak inverse 
correlation of this parameter with both the Span of log D (R2 = 0.24) and Molecular Mass (R2 = 
0.18). 
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Span of log D 
 
Compound pKa Hill slope log Dmax (log P) log Dmin Span of log D 
N,N-dimethylaminoethanol 8.19±0.09 1.43±0.47 -0.11±0.08 -1.48±0.04 1.37±0.09 
Tertiary amine monomer 6.35±0.09 0.64±0.07 -0.13±0.03 -1.77±0.04 1.65±0.05 
Benzoyl-PDT-T (1mer) 7.17±0.32 0.71±0.34 1.80±0.15 0.11±0.13 1.69±0.21 
DTT-T (2mer) 8.08±0.04 1.22±0.09 -0.20±0.03 -2.05±0.01 1.85±0.03 
Acetyl-PDT-T (1.5mer) 6.90±0.08 0.84±0.10 1.93±0.05 -0.04±0.04 1.96±0.07 
PEG2-T (1mer) 6.82±0.08 0.64±0.06 0.59±0.04 -1.76±0.04 2.34±0.06 
Diacetyl-PEG2-T (1.5mer) 7.12±0.08 0.54±0.05 1.29±0.07 -1.07±0.03 2.36±0.08 
DTT-T (1mer) 7.02±0.05 0.73±0.05 0.02±0.03 -2.43±0.03 2.45±0.05 
PEG2-T (2mer) 7.61±0.04 1.33±0.13 0.61±0.04 -1.92±0.03 2.53±0.05 
DTT-T (3mer) 7.69±0.23 0.76±0.25 0.46±0.19 -2.09±0.13 2.54±0.24 
PDT-T (1mer) 7.18±0.07 0.52±0.04 1.55±0.05 -1.42±0.04 2.97±0.07 
Diacetyl-PDT-T (1.5mer) 7.48±0.67 0.32±0.12 3.15±0.68 -0.10±0.21 3.25±0.81 
PDT-T (3mer) 7.18±0.01 1.55±0.12 2.06±0.02 -2.03±0.01 4.08±0.02 
PEG2-T (3mer) 7.85±0.13 0.72±0.13 1.20±0.19 -3.13±0.12 4.33±0.24 
PDT-T (2mer) 6.80±0.06 0.64±0.05 1.88±0.08 -2.72±0.07 4.60±0.11 
 
Of all the correlations between the possible combinations of parameters, the strongest one is 
between the Span of log D and Molecular Mass (R2 = 0.39). Smaller compounds seem to dominate 
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the upper half of the list and larger compounds occupying the lower half. The library is segregated 
into 3 main populations. The first is from 1.65 to 1.96 with no clear relation between its members. 
The second population is from 2.34 to 2.54, containing PEG2 and DTT members only. In the 3rd 
group, many of the PDT family are clustered at the higher end of the list (specifically 2- and 3- mers 
as outliers at 4.6 and 4.08 respectively). 
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Part 3. Inference of nanoscale intramolecular interactions between side-chains 
 Thus far, the log D curves give insight into interaction between the side-chain and backbone. 
For the various families and groupings of oligomers, there are some qualitative trends that link the 
pKa (which reflects protonation of the side chain) and hydrophobicity (which varies with choice of 
backbone group). We have not made any comment yet on the interaction between side-chains 
because the data from those curves are a bulk measurement. Again, this means that the data is blind 
to the distribution of ionization states in each solvent phase at each point on the log D curve. In this 
section, I discuss how equilibrium statistical mechanical models can be used to extract parameters 
that characterize those distributions. Then with knowledge of those parameters in hand, I then 
comment on interactions between side-chains that may be at play. 
 
Comparison of Different Protonation Models 
The overall objective is to model the equilibrium partitioning of a compound between an aqueous 
phase and an octanol phase. I start with an analysis of models for 3 possible protonation sites to 
illustrate the different models that might be used and what the appropriate choice is. Then I move to 
the case of 2- and 1- protonation site(s). I then test for fitting dependence of models based on the 
number of protonation sites. Finally, I use the fitted parameters from our models to interpret 
differences in the log D distributions for the compounds in our library. 
 
Models for 3 Protonation Sites 
The compound with 3 possible protonation sites corresponds to the 3 tertiary amines on the side-
chains of an oligoTEA 3-mer. The reservoir of protons available is given by the pH of the aqueous 
phase. In the table below, I outline the differences between 3 simple models from which we might 
be able to calculate the distributions of ionization states. 
 
Model 
Number 
Interacting protonation 
sites? 
Energetic difference in compound 
solvation energy between solvent phases? 
Model 1 No No 
Model 2 No Yes 
Model 3 Yes Yes 
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The models are different based on whether or not they make the assumption of (1) interacting 
protonation sites and (2) energetic difference in compound solvation energy between solvent phases. 
If the interacting protonation sites assumption is made, I chose the interaction to be modeled 
following a Pauling interaction model where all interactions are pairwise-symmetric. More elaborate 
models where higher-order interactions could be made, but I do not consider them here. If there is 
no energetic difference in compound solvation energy between the two solvent phases, termed 
symmetric solvent phases, then there is no energy difference associated with moving from the water 
to octanol phase. If there is a non-trivial energy difference, the compound has a different solvation 
energy in one phase compared to the other. Given the similarity of these models to Monod-Wyman-
Changeux (MWC) models famous in biochemistry literature (cite Monod 1978), I also refer to this as 
a MWC-type difference. This energetic difference is analogous to the energetic difference between a 
tense and a relaxed state in an allosteric receptor. For those not so familiar with that literature, a 
simpler analogy can be considered as follows. Imagine your body being in two states: either sitting 
down on a chair or standing on your two feet. There is an energy associated with each state, where 
for instance, the standing state is the higher energy state because it takes more effort to be standing 
up than it does to remain seated. Now imagine I give you a cane. Having this cane alters the energy 
associated with both the sitting and standing states. It would take significantly less energy to be in 
the standing state if you have a cane, whereas the cane might only marginally decrease the energy 
associated with the sitting state. This change in the energy associated with both states is the MWC-
type difference I refer to. The key power of the MWC model is that it provides a mechanism by 
which it is possible that changes to the system (analogous to the addition of the cane in our example 
here) can reverse the relative order of the energy of states (which could hypothetically make the 
sitting state higher in energy than the standing state)! 
Using the grand canonical ensemble where the system is a 3-site compound and the reservoir 
is represented by the free protons dispersed in water and octanol, I use the Gibbs factor to assign 
weights to the possible states in each phase. Then, I use the equilibrium probabilities of each state to 
calculate the partitioning of the compound between the aqueous and octanol phases. Calculations 
are adapted from examples given by Phillips et. al50 for hemoglobin modeling. 
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Model 1: Non-interacting protonation sites. No energetic difference in compound solvation energy 
between solvent phases (symmetric solvent phases) 
Phase Microstate Protonation State Weight 
Octanol _ _ _ 0 1 
Octanol * _ _ 1 𝑒AB(CDEFAG) 
Octanol _ * _ 1 𝑒AB(CDEFAG) 
Octanol _ _ * 1 𝑒AB(CDEFAG) 
Octanol * * _ 2 𝑒AB(ICDEFAIG) 
Octanol _ * * 2 𝑒AB(ICDEFAIG) 
Octanol * _ * 2 𝑒AB(ICDEFAIG) 
Octanol * * * 3 𝑒AB(KCDEFAKG) 
Water _ _ _ 0 1 
Water * _ _ 1 𝑒AB(CLAG) 
Water _ * _ 1 𝑒AB(CLAG) 
Water _ _ * 1 𝑒AB(CLAG) 
Water * * _ 2 𝑒AB(ICLAIG) 
Water _ * * 2 𝑒AB(ICLAIG) 
Water * _ * 2 𝑒AB(ICLAIG) 
Water * * * 3 𝑒AB(KCLAKG) 
 
Here, the state reflects which of the side-chains have been protonated, with the total number of 
side-chains protonated given by the protonation state. The symbols for the weights are defined as 
follows: 𝛽 ≡ OPQR is the inverse temperature,  𝜖TUV is the energetic cost of adding 1 proton to the 
compound when the compound is in the octanol phase, 𝜖W is the energetic cost of adding 1 proton 
to the compound when the compound is in the aqueous phase, 𝜇 is the chemical potential 
associated with moving 1 proton from the reservoir into the system (i.e. protonating the 
macromolecule). 
 The weights are given in accordance with states defined in a grand canonical ensemble. A 
short explanation is given as follows. Consider a system and a surrounding reservoir that are isolated 
but allowed to exchange heat and particles with each other. A state then refers to an ensemble 
containing microstates that are indistinguishable from each other according to some property (ex. 
here that property is the protonation state). A fundamental postulate of statistical thermodynamics 
states that each microstate within a state has equal probability of being occupied. It follows then that 
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the probability of observing a system in a particular state i, PZ[Z\]^(statec), is proportional to the 
multiplicity of that state, WZ[Z\]^(statec): PZ[Z\]^(statec), ∝ WZ[Z\]^(statec) 
The multiplicity is related to a quantity known as the entropy through Boltzmann’s equation: S = k	ln	W 
If the system has a multiplicity, WZ[Z\]^ , and the reservoir, Wi]Z]ijkci , then:  W\k\lm = WZ[Z\]^ ∙ Wi]Z]ijkci 
And by extension: S\k\lm = SZ[Z\]^ + Si]Z]ijkci 
Since we make the specification that the system is in a particular state i, then WpqpVrs = 1 and SZ[Z\]^ = 0. It turns out then that the probability of state i is a function of Si]Z]ijkci. PZ[Z\]^(statec), ∝ etuvwvuxyzu(Z\l\]{)|  
Using the fundamental thermodynamic relation, dS = }O~ (dE + PdV + −µdN), PZ[Z\]^(statec), ∝ e O|~(A) 
In the grand canonical ensemble, the chemical potential (µ), the volume (V), and temperature (T) are 
constant, which reduces the expression to:  PZ[Z\]^(statec), ∝ e O|~(A) 
Since the total energy and particles between the system and reservoir are conserved and the 
temperature of the system and reservoir will be equal at equilibrium, 
System Energy (E)+ Reservoir Energy (E) = Total Energy (E~) 
System Particle Number (N) + Reservoir Particle Number (N) = Total Particle Number (N~) 
System Temperature (T) = Reservoir Temperature (T) 
one can make substitutions to put the expression in terms of system variables. PZ[Z\]^(statec), ∝ e}AO|~(A) 
The weight for a state is simply equal to the quantity on the right-hand side specific for that state. Weight(statec) = eA(zAz) 
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 With the weights for all the states defined, that directly allows one to write expressions for 
the probability of each state. Therefore, I can write the distribution coefficient in terms of the 
probabilities of all the protonation states of the compound in the octanol phases and the 
probabilities of all the protonation states of the compound in the aqueous phase. Here, I derive an 
expression of D that can be fit using the experimental data. 
 𝐷 ≡ Distribution	coefficient ≡ Equilibrium	concentration	of	all	states	in	the	octanol	phaseEquilibrium	concentration	of	all	states	in	the	water	phase  𝐷 = ∑ 𝑃TUVT, 𝑖¡∑ 𝑃WVr¢, 𝑗¤= (1 + 𝑒AB(CDEFAG) + 𝑒AB(CDEFAG) + 𝑒AB(CDEFAG) + 𝑒AB(ICDEFAIG) + 𝑒AB(ICDEFAIG) + 𝑒AB(ICDEFAIG) + 𝑒AB(KCDEFAKG))/𝑍(1 + 𝑒AB(CLAG) + 𝑒AB(CLAG) + 𝑒AB(CLAG) + 𝑒AB(ICLAIG) + 𝑒AB(ICLAIG) + 𝑒AB(ICLAIG) + 𝑒AB(KCLAKG))/𝑍  = 1 + 3𝑒AB(CDEFAG) + 3𝑒AB(ICDEFAIG) + 𝑒AB(KCDEFAKG)1 + 3𝑒AB(CLAG) + 3𝑒AB(ICLAIG) + 𝑒AB(KCLAKG)  
 For	dilute	solutions	(these	experiments	are	sub	mM), I	can	use	the	substitution	𝜇 = 𝜇« + ln } 𝑐𝑐«𝛽 ∶	 
𝐷 = OKr­®¯°DEF­(±²³´µ
EE²® )¶Kr­®¯·°DEF­·(±²³´µ
EE²® )¶r­®¯¸°DEF­¸(±²³´µ
EE²® )¶
OKr­®¯°L­(±²³´µ
EE²® )¶Kr­®¯·°L­·(±²³´µ
EE²® )¶r­®¯¸°L­¸(±²³´µ
EE²® )¶ 	  
= 1 + 3𝑒ABCDEFBG²m¹} UU² + 3𝑒AIBCDEFIBG²I m¹} UU² + 𝑒AKBCDEFKBG²K m¹} UU²1 + 3𝑒ABCLBG²m¹} UU² + 3𝑒AIBCLIBG²I m¹} UU² + 𝑒AKBCLKBG²K m¹} UU²  
 Using	c = [H]	and	defining	ln	with	log:	 
= 1 + 3𝑒ABCDEFBG²mk¿[À³]mk¿(r) Am¹	(Á²) + 3𝑒AIBCDEFIBG²I(mk¿[À³]mk¿(r) A m¹(Á²)) + 𝑒AKBCDEFKBG²K(mk¿[À³]mk¿(r) A m¹(Á²))1 + 3𝑒ABCLBG²mk¿[À³]mk¿(r) Am¹	(Á²) + 3𝑒AIBCLIBG²I(mk¿[À³]mk¿(r) A m¹(Á²)) + 𝑒AKBCLKBG²K(mk¿[À³]mk¿(r) A m¹(Á²))  
 Using	pH = −log[H]: 
= 1 + 3𝑒ABCDEFBG²A ÂÀmk¿(r) Am¹	(Á²) + 3𝑒AIBCDEFIBG²AI ÂÀmk¿(r)A Im¹(Á²) + 𝑒AKBCDEFKBG²AK ÂÀmk¿(r) AK m¹(Á²)1 + 3𝑒ABCLBG²A ÂÀmk¿(r)Am¹	(Á²) + 3𝑒AIBCLIBG²AI ÂÀmk¿(r) A Im¹(Á²) + 𝑒AKBCLKBG²AK ÂÀmk¿(r) AK m¹(Á²)  
 Collecting	β	terms	and	define:							𝑜𝑐𝑡 ≡ 𝛽(𝜖TUV − 𝜇«)        𝑤𝑎𝑡𝑒𝑟 ≡ 𝛽(𝜖W − 𝜇«)	 
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= 1 + 3𝑒ATUVA ÂÀmk¿(r)Am¹	(Á²) + 3𝑒AITUVAI ÂÀmk¿(r)A Im¹(Á²) + 𝑒AKTUVAK ÂÀmk¿(r)AK m¹(Á²)1 + 3𝑒AWVr¢A ÂÀmk¿(r)Am¹	(Á²) + 3𝑒AIWVr¢AI ÂÀmk¿(r) A Im¹(Á²) + 𝑒AKWVr¢AK ÂÀmk¿(r) AK m¹(Á²) 
 Taking	log	of	both	sides: 
𝐥𝐨𝐠𝑫 = 𝐥𝐨𝐠 Ê 𝟏 + 𝟑𝒆A𝒐𝒄𝒕A 𝒑𝑯𝒍𝒐𝒈(𝒆) A 𝒍𝒏(𝒄𝟎) + 𝟑𝒆A𝟐𝒐𝒄𝒕A𝟐 𝒑𝑯𝒍𝒐𝒈(𝒆)A 𝟐𝒍𝒏(𝒄𝟎) + 𝒆A𝟑𝒐𝒄𝒕A𝟑 𝒑𝑯𝒍𝒐𝒈(𝒆)A𝟑 𝒍𝒏(𝒄𝟎)𝟏 + 𝟑𝒆A𝒘𝒂𝒕𝒆𝒓A 𝒑𝑯𝒍𝒐𝒈(𝒆)A 𝒍𝒏(𝒄𝟎) + 𝟑𝒆A𝟐𝒘𝒂𝒕𝒆𝒓A𝟐 𝒑𝑯𝒍𝒐𝒈(𝒆) A 𝟐𝒍𝒏(𝒄𝟎) + 𝒆A𝟑𝒘𝒂𝒕𝒆𝒓A𝟑 𝒑𝑯𝒍𝒐𝒈(𝒆) A𝟑 𝒍𝒏(𝒄𝟎)Û 
 
Given experimental data of log D vs. pH, I fit for the parameters oct and water. The value 𝑐« was set 
to 10-7 because that is the concentration of protons in water at the neutral pH of 7, which is a natural 
reference state. 
 
This above graph shows what happens if you try to fit this model with data from the PDT-T 3-mer. 
Clearly, this is not a good model. The model cannot produce log D values greater than 0. After 
inspecting Model 2, it will be apparent that the issue is due to assumption of symmetric solvent 
phases. 
 
Model 2: Non-interacting protonation sites. Non-trivial energetic difference in compound solvation 
energy between solvent phases 
Phase Microstate Protonation State Weight 
Octanol _ _ _ 0 1 
Octanol * _ _ 1 𝑒AB(CDEFAG) 
Octanol _ * _ 1 𝑒AB(CDEFAG) 
Octanol _ _ * 1 𝑒AB(CDEFAG) 
Octanol * * _ 2 𝑒AB(ICDEFAIG) 
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Octanol _ * * 2 𝑒AB(ICDEFAIG) 
Octanol * _ * 2 𝑒AB(ICDEFAIG) 
Octanol * * * 3 𝑒AB(KCDEFAKG) 
Water _ _ _ 0 𝑒ABC  
Water * _ _ 1 𝑒AB(CLAGC) 
Water _ * _ 1 𝑒AB(CLAGC) 
Water _ _ * 1 𝑒AB(CLAGC) 
Water * * _ 2 𝑒AB(ICLAIGC) 
Water _ * * 2 𝑒AB(ICLAIGC) 
Water * _ * 2 𝑒AB(ICLAIGC) 
Water * * * 3 𝑒AB(KCLAKGC) 
 
In comparison to Model 1, the key conceptual difference with Model 2 is the introduction of 
an energy cost (𝜖) of the compound being in the water phase (the energy cost of being in the 
octanol phase is defined for convenience as 0). This is more realistic than Model 1 because one 
would not expect the solvation energy of the compound in water to be the same as the solvation 
energy of the compound in octanol. This model is MWC-like because the protonation reaction has 
different energy costs depending on the solvent phase, which is analogous to the MWC model in 
enzymes where a ligand has a different binding affinity depending on the conformation of the 
enzyme. A positive 𝜖 indicates the solvation energy in the octanol phase is less than the solvation 
energy in the aqueous phase. Conversely, a negative 𝜖 indicates the solvation energy in the octanol 
phase is greater than the solvation energy in the aqueous phase. A calculation for D for Model 2 can 
be done following the same steps outlined above for Model 1. 𝐷 = ∑ 𝑃TUVT, 𝑖¡∑ 𝑃WVr¢, 𝑗¤= (1 + 𝑒AB(CDEFAG) + 𝑒AB(CDEFAG) + 𝑒AB(CDEFAG) + 𝑒AB(ICDEFAIG) + 𝑒AB(ICDEFAIG) + 𝑒AB(ICDEFAIG) + 𝑒AB(KCDEFAKG))/𝑍(𝑒ABC + 𝑒AB(CLAGC) + 𝑒AB(CLAGC) + 𝑒AB(CLAGC) + 𝑒AB(ICLAIGC) + 𝑒AB(ICLAIGC) + 𝑒AB(ICLAIGC) + 𝑒AB(KCLAKGC))/𝑍 = 1 + 3𝑒AB(CDEFAG) + 3𝑒AB(ICDEFAIG) + 𝑒AB(KCDEFAKG)𝑒−𝛽𝜖 + 3𝑒−𝛽(𝜖𝑤−𝜇+𝜖) + 3𝑒−𝛽(2𝜖𝑤−2𝜇+𝜖) + 𝑒−𝛽(3𝜖𝑤−3𝜇+𝜖) 
 Following	the	same	intermediate	steps	as	Model	1, with	this	additional	definition:     𝑑𝑖𝑓𝑓 ≡ 𝛽𝜖 
 𝐥𝐨𝐠𝑫= 𝐥𝐨𝐠 Ê 𝟏 + 𝟑𝒆A𝒐𝒄𝒕A 𝒑𝑯𝒍𝒐𝒈(𝒆) A 𝒍𝒏(𝒄𝟎) + 𝟑𝒆A𝟐𝒐𝒄𝒕A𝟐 𝒑𝑯𝒍𝒐𝒈(𝒆)A 𝟐𝒍𝒏(𝒄𝟎) + 𝒆A𝟑𝒐𝒄𝒕A𝟑 𝒑𝑯𝒍𝒐𝒈(𝒆)A𝟑 𝒍𝒏(𝒄𝟎)𝒆A𝒅𝒊𝒇𝒇 + 𝟑𝒆A𝒘𝒂𝒕𝒆𝒓A𝒅𝒊𝒇𝒇A 𝒑𝑯𝒍𝒐𝒈(𝒆)A 𝒍𝒏(𝒄𝟎) + 𝟑𝒆A𝟐𝒘𝒂𝒕𝒆𝒓A𝒅𝒊𝒇𝒇A𝟐 𝒑𝑯𝒍𝒐𝒈(𝒆)A 𝟐𝒍𝒏(𝒄𝟎) + 𝒆A𝟑𝒘𝒂𝒕𝒆𝒓A𝒅𝒊𝒇𝒇A𝟑 𝒑𝑯𝒍𝒐𝒈(𝒆)A𝟑 𝒍𝒏(𝒄𝟎)Û 
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The graph above is the same data set for the PDT-T 3-mer, now fitted with Model 2 for parameters 
oct, water, and diff. Thus, it is apparent that one requires an energetic difference between the two 
solvent phases to qualitatively recapitulate the experimental data. For the most part, this model 
seems to fit quite well. Flanking the inflection point, the model is too shallow and does not quite 
match the experimental data points corresponding to pH of 6 and 8. 
 
Model 3: Interacting (Pauling model) protonation sites. Non-trivial energetic difference in 
compound solvation energy between solvent phases 
Phase Microstate Protonation 
State 
Number of 
Protonated Pairs 
Weight 
Octanol _ _ _ 0 0 1 
Octanol * _ _ 1 0 𝑒AB(CDEFAG) 
Octanol _ * _ 1 0 𝑒AB(CDEFAG) 
Octanol _ _ * 1 0 𝑒AB(CDEFAG) 
Octanol * * _ 2 1 𝑒AB(ICDEFAIGá) 
Octanol _ * * 2 1 𝑒AB(ICDEFAIGá) 
Octanol * _ * 2 1 𝑒AB(ICDEFAIGá) 
Octanol * * * 3 3 𝑒AB(KCDEFAKGKá) 
Water _ _ _ 0 0 𝑒ABC  
Water * _ _ 1 0 𝑒AB(CLAGC) 
Water _ * _ 1 0 𝑒AB(CLAGC) 
Water _ _ * 1 0 𝑒AB(CLAGC) 
Water * * _ 2 1 𝑒AB(ICLAIGCá) 
Water _ * * 2 1 𝑒AB(ICLAIGCá) 
Water * _ * 2 1 𝑒AB(ICLAIGCá) 
Water * * * 3 3 𝑒AB(KCLAKGCKá) 
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In comparison with Model 2, the key conceptual difference with Model 3 is the introduction 
of interacting sites. Borrowing terminology again from biochemistry, the presence of interaction is 
given the name cooperativity. There is an energy difference (J) associated with protonating the 
compound if it has already been protonated. In this model, I only consider pairwise cooperativity (a 
Pauling interaction model), which means there is an additional amount of energy J for each pair of 
protonated sites in the state. This assumes all pairwise interactions among sites are symmetric in 
energy. Here a positive J indicates negative cooperativity, meaning existing protonated sites make it 
more difficult for another side-chain to become protonated. Conversely, a negative J indicates 
positive cooperativity, meaning existing protonated sites make it easier for another side-chain to 
become protonated. Again, a calculation for D for Model 3 can be done following the same steps 
outlined above for Model 1. 
 𝐷 = ∑ 𝑃TUVT , 𝑖¡∑ 𝑃WVr¢, 𝑗¤= (1 + 𝑒AB(CDEFAG) + 𝑒AB(CDEFAG) + 𝑒AB(CDEFAG) + 𝑒AB(ICDEFAIGá) + 𝑒AB(ICDEFAIGá) + 𝑒AB(ICDEFAIGá) + 𝑒AB(KCDEFAKGKá))/𝑍(𝑒ABC + 𝑒AB(CLAGC) + 𝑒AB(CLAGC) + 𝑒AB(CLAGC) + 𝑒AB(ICLAIGCá) + 𝑒AB(ICLAIGCá) + 𝑒AB(ICLAIGCá) + 𝑒AB(KCLAKGCKá))/𝑍 = 1 + 3𝑒AB(CDEFAG) + 3𝑒AB(ICDEFAIGá) + 𝑒AB(KCDEFAKGKá)𝑒ABC + 3𝑒AB(CLAGC) + 3𝑒AB(ICLAIGCá) + 𝑒AB(KCLAKGCKá) 
 Following	the	same	intermediate	steps	as	Model	2, with	this	additional	definition:     𝑖𝑛𝑡 ≡ 𝛽𝐽 
 𝐥𝐨𝐠𝑫= 𝐥𝐨𝐠Ê 𝟏 + 𝟑𝒆A𝒐𝒄𝒕A 𝒑𝑯𝒍𝒐𝒈(𝒆)A 𝒍𝒏(𝒄𝟎) + 𝟑𝒆A𝟐𝒐𝒄𝒕A𝒊𝒏𝒕A𝟐 𝒑𝑯𝒍𝒐𝒈(𝒆) A𝟐𝒍𝒏(𝒄𝟎) + 𝒆A𝟑𝒐𝒄𝒕A𝟑𝒊𝒏𝒕A𝟑 𝒑𝑯𝒍𝒐𝒈(𝒆)A𝟑 𝒍𝒏(𝒄𝟎)𝒆A𝒅𝒊𝒇𝒇 + 𝟑𝒆A𝒘𝒂𝒕𝒆𝒓A𝒅𝒊𝒇𝒇A 𝒑𝑯𝒍𝒐𝒈(𝒆)A 𝒍𝒏(𝒄𝟎) + 𝟑𝒆A𝟐𝒘𝒂𝒕𝒆𝒓A𝒅𝒊𝒇𝒇A𝒊𝒏𝒕A𝟐 𝒑𝑯𝒍𝒐𝒈(𝒆)A𝟐𝒍𝒏(𝒄𝟎) + 𝒆A𝟑𝒘𝒂𝒕𝒆𝒓A𝒅𝒊𝒇𝒇A𝟑𝒊𝒏𝒕A𝟑 𝒑𝑯𝒍𝒐𝒈(𝒆)A𝟑𝒍𝒏(𝒄𝟎)Û 
 
 
Revisiting the data set for the PDT-T 3-mer again, after fitting with Model 3, the inclusion of 
cooperativity allows the best fit to the experimental data yet. For this particular data set, this suggests 
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the protonation of a side chain is to some extent influenced by the protonation state of neighboring 
side chains.  
 
 
Model for 3 Sites AICc 
Model 1 (Symmetric phases, non-interacting) 18.14 
Model 2 (MWC-type, non-interacting) -67.86 
Model 3 (MWC-type, Pauling interactions) -118.6 
 
While it was qualitatively easy to pick out the best model by visual inspection for this data 
set, I used the small-sample-size corrected version of the Akaike information criterion (AICc) to 
objectively select the best model (discussion of this criteria is done in the Comparing Models with 
AICc section of the Supporting Information). Comparing all 3 models, Model 3 best fits the 
experimental data from the 3 choices because a more negative AICc corresponds to a better model. 
This suggests that there must be an energy difference for the compound to be in the aqueous phase 
versus in the octanol phase and that there is some degree of interaction (cooperativity) between 
protonated groups on the compound. 
It is important to note that Model 3 is also the most general model. In other words, in the 
appropriate limits, we can recover the other two models. Setting 𝐽 = 0 in Model 3 recovers Model 2. 
Setting	𝐽 = 0, 𝜖 = 0 in Model 3 recovers Model 1. Thus, it shows that assumptions of independent 
sites and symmetric solvent phases cannot be made for the PDT-T 3-mer data set. The data suggests 
the J and 𝜖 parameters are needed to explain the data and not simply a means to overfit the data. For 
this particular compound, the models suggest there are indeed nanoscale intramolecular interactions 
between side-chains taking place, something that could not be revealed by only the bulk 
measurement. 
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Models for 2 Protonation Sites 
One can repeat the same procedure used for 3 sites to derive the expressions for log D for 2 
sites. The only real difference moving from a system with 3 protonation sites to a system of 2 
protonation is in the enumeration of possible states the system can be in. The expressions for log D 
essentially take on the same form, just with different coefficients. The results for the 3 different 
models are shown below for the PEG2-T 2-mer data set. 
 
Model for 2 Sites AICc 
Model 1 (Symmetric phases, non-interacting) -31.39 
Model 2 (MWC-type, non-interacting) -72.16 
Model 3 (MWC-type, Pauling interactions) -84.34 
 
Again, I see the assumption of symmetric solvent phases results in the worst model. In this case, the 
inclusion of interaction terms resulted in the best model, suggesting for the PEG2-T 2-mer there 
should be cooperativity occurring between side-chains. 
 As a control, when I try to fit the 2-mer data with models made for 3 sites or 1 site, 
comparison of AICc shows that the fit will not be as models made for 2 sites. This is not the same 
as overfitting because changing the number protonation sites does not increase the number of 
parameters in the model; rather, it changes the weights and multiplicities of the states (see the 
Testing for Fitting Dependence on the Number of Protonation Sites section in the Supplementary 
Information). This indicates the Gibbs distribution should only correspond with accurate weights 
and multiplicities once you have defined the number of protonation states by properly enumerating 
the states.  
 
Models for 1 Protonation Site 
Finally, I play this game again for the limiting case of 1 protonation site. There still is the 
option of picking between symmetric solvent phases or a non-trivial energetic difference in 
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compound solvation energy between solvent phases. However, having only 1 protonation site 
excludes the possibility for interaction effects because there would not be another side-chain to 
physically interact with. I therefore limit this analysis to only Model 1 and Model 2 for the case of 1 
protonation site. Shown below is the comparison of these models for the PDT-T 1-mer. 
 
Model for 1 Site AICc 
Model 1 (Symmetric phases, non-interacting) -0.798 
Model 2 (MWC-type, non-interacting) -83.82 
 
As seen for the other 2 compounds, there must be a solvation energy difference to recapitulate the 
data for the PDT-T 1-mer.  
While it is not a physically reasonable model, Model 3 was fit with data for the 1-mers. And 
in all cases, the AICc picks either Model 1 or Model 2 as better than Model 3, which is reassuring 
that the criteria penalizes models that use extra parameters to overfit the data (see Testing AICc on 
Overfitting of 1-mers section in the Supporting Information). 
 
Analysis of Model Parameters in the oligoTEA Library 
Armed with the log D expressions, I find the best model for each compound in the 
oligoTEA library from the 3 possible models according to the lowest AICc value. The AICc values 
for all models are shown below and further commented on in Comparing Models with AICc in the 
Supporting Information.  
 
Oligomer 
AICc Value 
Model 1 
(2 parameters) 
AICc Value 
Model 2 
(3 parameters) 
AICc Value 
Model 3 
(4 parameters) 
Notes on comparing AICc values between models 
Acetyl-DTT-T (1 mer) -102.8 -100.1  Model 1 has a probability ratio of 3.82 over Model 2 (79% to 21%) 
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Acetyl-DTT-T (2 mer) -175 -193.1 -206.8  
Acetyl-DTT-T (3 mer) -31.27 -34.41 -31.4 
Model 2 has a probability ratio of 4.49 over Model 
3 (82% to 18%). Model 2 has a probability ratio of 
4.81 over Model 1 (83% to 17%) 
 
    
Acetyl-PDT-T (1 mer) -0.798 -83.82   
Acetyl-PDT-T (2 mer) 11.46 -110.8 -109.7 Model 2 has a probability ratio of 1.72 over Model 3 (63% to 37%) 
Acetyl-PDT-T (3 mer) 18.14 -67.86 -118.6  
 
    
Acetyl-PEG2-T (1 mer) -77.68 -155   
Acetyl-PEG2-T (2 mer) -31.39 -72.16 -84.34  
Acetyl-PEG2-T (3 mer) -12.07 -36.14 -34.52 Model 2 has probability ratio of 2.25 over Model 3 (69% to 31%) 
 
The following table aggregates the best model for each compound and the corresponding 
value of the fitted parameters from that model. I look for correlations in the parameters and see if 
they can give us any insight on if interactions between side-chains are occurring. And if there are 
interactions, are they impacted by the molecular topology? 
 
 
  
Compound Best-fitting Model Parameters 
  oct water diff int 
Acetyl-PDT-T (1 mer) Model 2 (MWC-like, non-interacting) 2.868 -3.661 3.402  
Acetyl-PDT-T (2 mer) Model 2 (MWC-like, non-interacting) 3.058 -2.11 4.19  
Acetyl-PDT-T (3 mer) Model 3 (MWC-like, Pauling interactions) 3.516 0.382 4.741 -2.394 
      
Acetyl-DTT-T (1 mer) Model 1 (symmetric phases, non-interacting) 2.796 -2.791   
Acetyl-DTT-T (2 mer) Model 3 (MWC-like, Pauling interactions) -0.465 -2.597 -0.462 -1.928 
Acetyl-DTT-T (3 mer) Model 2 (MWC-like, non-interacting) -0.599 -2.482 0.9045  
      
Acetyl-PEG2-T (1 mer) Model 2 (MWC-like, non-interacting) 3.078 -2.195 1.288  
Acetyl-PEG2-T (2 mer) Model 3 (MWC-like, Pauling interactions) 3.28 0.382 1.389 -6.363 
Acetyl-PEG2-T (3 mer) Model 2 (MWC-like, non-interacting) -0.266 -3.489 2.539  
48 
 
oct and water Parameters 
There are a couple trends for the oct and water parameters within families of compounds, but 
there is no apparent global pattern. Recall the two parameters (defined as 𝑜𝑐𝑡 ≡ 𝛽(𝜖TUV − 𝜇«)  and 𝑤𝑎𝑡𝑒𝑟 ≡ 𝛽(𝜖W − 𝜇«) ) indicate the energy associated with protonating a site while the compound is 
in the octanol or aqueous phase respectively. For oct, the value increases with mer length for the 
PDT family. For water, the value increases with mer length for the PDT and DTT family. 
 
diff Parameter 
It is quite clear the MWC-like models dominate the list, and the only case where a symmetric 
phase assumption seems to be applicable is the DTT 1mer. The diff parameter (defined as 𝑑𝑖𝑓𝑓 ≡𝛽𝜖) reflects the difference in the energy of the compound to be solvated in the octanol phase versus 
in the aqueous phase. In hindsight, it makes logical sense that a difference in solvation energy is 
needed to help drive asymmetric partitioning of the compound into the two phases. From looking at 
the relative values of diff from fitting, we recapitulate the expected trend from knowing the relative 
hydrophobicities of the backbone dithiol comonomer. Indeed, comparing the values of diff with 
another parameter that reflects hydrophobicity, such as log Dmin (log P), produces near perfect 
correlation.  
 
Dmax (log P) 
Dmax (log P) 
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Diff has the greatest values for the hydrophobic PDT family, the lowest values for the 
hydrophilic DTT family, and intermediate values for the PEG2 family. Across all families, diff 
increases with mer length. This suggests that in general, oligoTEAs with tertiary amine side-chains 
become more hydrophobic the longer their sequences. This is consistent with the idea that 
increasing the size of hydrophobic objects increases the free-energy cost of keeping them in a 
hydrophilic environment51–53. This parameter also shows that the backbone provides the dominate 
contribution to the compound’s hydrophobicity because the diff parameter for the tertiary amine 
monomer is -0.29, which indicates it is slightly hydrophilic. In contrast, nearly all of the compounds 
in the library are hydrophobic. 
 
int Parameter 
For compounds where interactions between protonation sites are possible (i.e. the 2- and 3- 
mers), for half of those compounds the interacting Pauling model is the best fitting model. Based on 
the sign of the int parameter (defined as 𝑖𝑛𝑡 ≡ 𝛽𝐽), a positive value indicates a negative cooperativity 
(i.e. an additional protonation from the n-1 protonation state is more energetically costly than if the 
sites were independently protonated) and a negative value indicates positive cooperativity. The only 
discernable trend is that when there is cooperativity, it is of the positive form, where protonated 
side-chains make it easier for fellow side-chains to become protonated. There is even no continuity 
in the type of cooperativity among families. In the PEG2 and DTT families, going from the 2- to 
the 3- mers results in the loss of positive cooperativity. And in the PDT family, going from the 2- to 
the 3- mers results in gaining cooperativity. This implies cooperativity is a nonlinear function of mer 
length. 
This can perhaps be explained by realizing that the effective shape of the molecule in 
solution is also a nonlinear function of the mer length.  While a site might be favorably positioned 
for protonation in the 2-mer, the same site might see an entirely different local environment in the 
3-mer. While the values of this parameter suggest prediction of interaction for other compounds 
would be very difficult, this generally does answer the question on the existence of electrostatic 
interactions between side-chains. The calculations suggest that interactions do exist for some of the 
compounds in this library. 
A simple explanation as to why one should not be surprised that intramolecular interaction 
between side-chains is possible is through the heuristic of the Debye screening length. Since I used 
PBS 1x salt solution to make the aqueous layers, using a salt concentration of roughly 200mM, the 
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Debye length can be estimated to be ~0.7nm50. This is the effective maximum length to which a 
charge influences another charge in aqueous solution at that salt concentration. And since these 
oligoTEAs are known to be geometrically smaller than that length54, then I should preliminary 
expect the possibility of electrostatic interaction. It is somewhat surprising then that not all of the 
multi-mers display some significant degree of interaction. However, the nature of that interaction 
will depend importantly on how the protonation sites are oriented with respect to each other in 3-D 
space. Studies have shown that relative orientation affects the interaction between hydrophobic and 
charged/polar surfaces46. While I cannot experimentally see how the sites are orientated with respect 
to each other, perhaps to some extent those effects might be in play here.  
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Conclusion 
 Motivated by the need for endosomal escape agents in applications such as siRNA drug 
delivery, this study sought to uncover some of the design principles related to controlling oligoTEA 
pKa and hydrophobicity. Emphasis was placed on understanding possible interactions between side-
chains and interactions between the side-chain and backbone. By designing a library of different 
backbone hydrophobicities and different mer lengths, I could begin investigating these interactions.  
Using the shake flask method, I was able make bulk measurements of compound 
partitioning at microscopic resolution for an extended library of compounds. By repeating the 
method for aqueous solutions of different pH, one can trace out a log D curve for each compound. 
This methodology conveniently allows for measurement of pKa and various parameters of 
hydrophobicity simultaneously from the log D curves.  
Resulting analysis of the two parameters show some interesting trends that might be useful 
in design of an endosomal escape agent. The pKa’s of all compounds tested lie within the range of 6 
to 8, which happens to be within the relevant window for pH maturation in the endosome. This 
suggests the tertiary amine could be a reasonable candidate for a side-chain group for that 
hypothesized agent. 
The data suggests there is only a small degree of interaction between the side-chain and 
backbone. This is evidenced by the fact that among the 1-mers, the choice of backbone dithiol does 
not change the pKa to any significant extent. The same observation is made for the 3-mers and to 
some extent the 2-mers. This is somewhat surprising given that the pKa of a proxy for the tertiary 
amine subunit itself was measured to be about 2 units different from the tertiary amine when it is 
part of an oligoTEA allyl acrylamide monomer unit, which suggested the local environment of the 
backbone might affect the pKa. This lack of interaction is shown also by library members with 
additional modifications. When the end cap of one of the oligomers was changed, there was no 
appreciable difference on its pKa relative to the normal capped counterpart. And when 1.5 mers 
were made, which should have increased possible interactions between the side-chain and backbone 
over their integer counterparts, there was again no large change in pKa. Perhaps then the dithiol 
comonomer is too far from the tertiary amine topologically to have a significant interaction. 
Analysis of the pKa and hydrophobicity parameters show that there is some correlation 
between parameter values of some composite oligoTEAs and the parameter values of the individual 
components that constitute them. The hydrophobicity of the backbone component seems to be 
crucial to the hydrophobicity of the overall construct. The relative hydrophobicity between choices 
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of backbone dithiol are preserved when looking at the log Dmin and log P hydrophobicity values of 
the oligoTEA library. It is also seen the presence of additional backbone units (in the 1.5 mers) can 
significantly move these parameter values away from their integer counterparts. The diff parameter 
also suggests that the contribution of the backbone to hydrophobicity dominates over the side-
chain’s contribution because nearly all the library members are hydrophobic, whereas the diff value 
for the tertiary amine monomer shows it is slightly hydrophilic. Another interesting correlation was 
the span of log D as a function of size. The tertiary amine monomer had the smallest log D span. As 
one increased mer length, in general the span grew larger; this suggests increasing length allows one 
to increase the operating range of compound hydrophobicity. The existence of such correlations is 
useful from a design perspective in that they preserve the linear paradigm that the whole is the sum 
of its parts. 
 While I did not have direct evidence for interactions between side-chains, using theory I 
could infer the existence of such interactions for some of the members of the library. With a 
theoretical framework provided by equilibrium statistical mechanics, I made models that could 
calculate the equilibrium distributions for the partitioning of a compound with multiple protonation 
states into two phases. Using those distributions, I derived expressions for log D that could then be 
fitted with the experimental data. From fitting the parameters, for several of the multi-mers (PDT 3-
mer, DTT 2-mer, and PEG2 2-mer), a non-trivial int parameter predicts there are intramolecular 
interactions between side-chains occurring. For these particular compounds, it suggests the nature of 
the interaction between side-chains is that of positive cooperativity, where existing protonated sites 
make it more energetically favorable for another side-chain to become protonated. One possible 
explanation could be an electrical double-layer effect where the protonated side-chain causes the 
formation of negative charge layer around the side-chain, which in term forms a positive charge 
layer around that. And perhaps by coincidence, the other side-chain(s) happens to be at a distance 
that falls within that positive layer, which makes protonation more likely. 
Based on the compounds where interaction was inferred, it seems there is no discernable 
correlation between choice of backbone and interaction of the side-chains nor between mer length 
and interaction of the side-chains.  While a rudimentary calculation of a Debye length hinted that 
charge-charge effects are possible for molecules of the size of these compounds50, the general 
flexibility of oligoTEAs54 makes prediction of these interactions from molecular topology alone 
seemingly difficult without some kind of knowledge of their arrangement in 3-D space and their 
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dynamics. In the following Outlook section, I propose some potential directions the design of 
charge-charge interactions for future oligoTEAs. 
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Outlook 
 Inference using the models allowed me to make the claim there are interactions between 
side-chains occurring in some of the multi-mers. However, here I am not able to measure such an 
interaction directly. It would be interesting to see if there are any experimental techniques that might 
be able to confirm the presence or characterize the nature of these electrostatic interactions. 
Techniques such as ESR allow one to determine the distance between two moieties on the same 
molecule, but it is not quite clear if the addition of probes needed for such experiments would 
necessarily disturb the natural interaction between side-chains. 
While not pursued here, a logical next step beyond intramolecular interactions is studying the 
effects of intermolecular interactions. For instance, of interest would be characterizing 
cationic/zwitterion intermolecular interactions that may be typical between an endosomal escape 
agent and the lipids of the endosomal membrane. While it is difficult to imagine how that might be 
accomplished in vivo, techniques such as SPR might be able to shed some light on those interactions 
in an artificial setting. 
 For this library of compound, I restricted the side-chain to only being a tertiary amine. This 
was only done for convenience and simplicity, since it only has 1 ionization state. However, it would 
be interesting to study oligoTEAs with other side chains that have the possibility for carrying charge 
aside from the tertiary amine. It would be interesting to see if the models would reveal any side-
chain/side-chain interactions between those groups. 
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Supplementary Information 
Material and Methods 
i) N,N-dimethylethylamine monomer (tertiary amine monomer) synthesis 
Synthesis of the tertiary amine monomer is done in two main steps (acylation and alkylation) 
outlined as follows: 
 
 Acylation Step 
 Start with clean and dry glassware, stir bars, and starting materials. Into a round bottom 
flask, add 1g of N,N-dimethylethylenediamine. In a separate vial, dilute 1.2 molar equivalents of 
acryl chloride into 5 mL of dichloromethane (DCM) and set aside. Add 1.25 molar equivalents of 
trimethylamine (TEA) into the round bottom flask and enough DCM to make the final reaction 
mixture 0.15M (including the volume of the diluted acryl chloride). Seal the flask with a scepter and 
stir for 10 minutes. Cool the mixture down to ~0ᵒC on ice and let sit for 10-15 minutes. Add the 
diluted acryl chloride to the flask dropwise for 1 hour at ~0ᵒC. Then, stir the mixture on ice for 1 
hour. After, stir the mixture at room temperature for 1 hour. Quench the mixture with 10N NaOH. 
Extract the product into the organic layer using DCM. Use TLC to monitor extraction of product 
into organic layer. Use sodium sulfate to dry any residual water that may be left in the organic layer. 
Transfer the organic mixture to a new flask, and dry off the product. 
 
 Alkylation Step 
Start with clean and dry glassware, stir bars, and starting materials. In a vial, solubilize 1.2 
molar equivalents of allyl bromide in 1 mL of dry dimethylformamide (DMF) and set aside. In a 
round bottom flask, solubilize 1.5 molar equivalents of sodium hydride (NaH) in 10 mL of DMF. In 
a separate vial, solubilize the product of the acylation step in enough to DMF to make a 0.2M total 
reaction mixture (including the volumes of solubilized NaH and solubilized allyl bromide). Add the 
solubilized acylation product to the flask containing NaH. Stir the flask for 10 minutes at room 
temperature. Then stir at ~0ᵒC on ice, allowing the mixture to equilibrate for 15 minutes. Using a 
syringe, add the solubilized allyl bromide to the flask dropwise for ~45 minutes while keeping the 
flask on ice. Stir the flask on ice for 1 hour. Then, quench the mixture with a small volume of 1M 
HCl. Dry the contents of the flask, removing as much of the DMF as possible. Basify the mixture 
with 10N NaOH (making sure to check the pH of the aqueous becomes ≥ 14). Add MilliQ water to 
take up excess salts (checking that the water layer remains pH ≥ 14) Extract the product with DCM. 
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Use TLC to monitor extraction of product into organic layer. Use sodium sulfate to dry any residual 
water that may be left in the organic layer. Dry the product. Purify the product using ISCO 
purification ((optional hexanes wash) dichloromethane/ultra system) on a silica or basic alumina 
column. 
 
ii) Oligomer synthesis 
Synthesis of oligoTEAs follows a few main steps, as shown below. The methodology is 
adapted from one set forth by Porel et al33:  
 
Fluorous solid-phase extraction (FSPE) 
Dissolve the fluorous organic mixture to be separated with a small volume (1 equivalent) of 
methanol. Load that mixture onto a pre-packed fluorous solid phase extraction (FSPE) cartridge that 
has 1 equivalent of water on top of the column. Add 3 more equivalents of methanol to the top of 
the column and mix. Use a fluorophobic wash (80% methanol, 20% water) to elute all the non-
fluorous molecules, leaving the fluorous molecules retained on the fluorous silica gel. Use 2-5mL of 
fluorophobic wash per 10mg of fluorous-tagged product. Then use a fluorophilic wash (100% 
methanol) to elute the fluorous molecules from the fluorous stationary phase. Use 1-2mL of 
methanol per 10mg of fluorous-tagged product. 
 
Fluorous Boc-protected allyl amine 
Into 10 mL THF, solubilize 100 mg (~0.147mmol) of 2-[2-(1H,1H,2H,2H-Perfluoro-9-
methyldecyl)isopropoxycarbonyloxyimino]-2-phenylacetonitrile (fluorous BOC-ON), 1.2 molar 
equivalents of allyl amine, and 2 molar equivalents of TEA. Stir the reaction mixture at room 
temperature for at least 3 hours. Purify the product mixture using the FSPE process mentioned 
above in a 2g FSPE cartridge (using 20 mL of wash and eluting with 15 mL of methanol). Then dry 
off the product. 
 
Thiol-ene reaction 
In enough methanol to make a 100mM reaction mixture, add 1 molar equivalent (either 
fluorous Boc-protected allyl amine or a Michael addition product), 5 equivalents of dithiol, and 5 
mol% (relative to dithiol) of 2,2-dimethoxy-2-phenylacetophenone (DMPA). Irradiate the reaction 
mixture for 270 consecutive seconds at 20 mW/cm2. Stir the reaction vial to mix the contents. 
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Irradiate for an additional 90 seconds at mW/cm2. Purify the product mixture using the FSPE 
process mentioned above. Then dry off the product. 
 
Thiol-Michael addition 
In enough methanol to make a 100mM reaction mixture, add 1 molar equivalent of fluorous-
thiol, 2 equivalents of tertiary amine monomer, and 5 mol% (relative to monomer) of dimethyl 
phenyl phosphine (Me2PhP). Stir the mixture at room temperature for ~1 hour. The temperature 
and reaction time can be modified by knowing the kinetic data for the monomer on a specific thiol. 
Check for reaction completion by performing the DTDP assay. Purify the product mixture using the 
FSPE process mentioned above. Then dry off the product. 
 
Dithio-dipyridyl (DTDP) assay 
For each test, add 500 uL of a solution of 0.1% TEA in dimethyl sulfoxide (DMSO) to 8.33 
µL of 12 mM 2,2’-dipyridyldisulfide in DMSO. Add 0.5 µL of 0.1M Michael addition reaction 
mixture and allow to sit for 5 minutes.  Add 16.67 µL acetic acid and allow the mixture to react for 5 
minutes.  Make a blank using the same components but with 0.5 µL methanol instead of 0.5 µL 
Michael reaction mixture.  Pipette volumes from each assay in triplicate. Obtain absorbance values 
of the blank and test mixtures by scanning from 330-449 nm using an absorbance plate reader.  
Look for the reactant peak to decrease as a function of reaction time. If the curves of absorbance 
versus wavelength for the blank and test mixtures overlap, the reaction is deemed to be complete. 
 
Acetylation reaction 
Cleaved oligoTEA with primary amine (1.0 equiv), acetic anhydride (2.0 equiv.), and TEA 
(2.0 equiv.) in DCM (0.5 M) were added into a 4mL vial. The mixture was periodically shaken at 
room temperature for 2 hours. The reaction mixture was purified using HPLC. 
 
iii) log D shake-flask method to obtain distribution coefficients and pKa 
Experimental log D values were obtained using an adapted Eppendorf shake-flask method55. 
Take a known mass of analyte (quantified via qNMR using a benzene standard) and dissolve in 
600uL of Milli-Q water (Solution A). Make 10 different pH solutions using PBS 1x buffer and 
titrating with HCl and NaOH. In a 2mL screw-top vial, add 50uL of Solution A; then add 550 uL of 
appropriate pH solution and 600uL of octan-1-ol. Repeat for a total of 10 different vials for each pH 
63 
 
solution (Test Solutions). For 2 other 2mL vials, add 50uL of Solution A to each. To one add 550uL 
of Milli-Q water; to the other, dry off the solvent and resuspend in 600uL of octan-1-ol (Standards 
1). These are standards for each phase with concentrations on the order of the 10 different pH vials. 
From each standard, take 100uL and mix with 900uL of Milli-Q water/octan-1-ol for a 10x serial 
dilution (Standards 2). Perform an additional 10x serial dilution (Standards 3). Vortex the Test 
Solutions for 1 minute and sonicate for an additional 15 minutes. This will allow the analyte to 
equilibrate between the 2 phases, so excess mixing is allowed. If either phase appears cloudy, 
centrifuge (<3000 rpm) the vials in multiples of 1 minute until both phases appear clear; a cloudy 
phase indicates water/octanol emulsions, which would distort phase quantifications later. Pipette 
500uL from each phase into a 2mL screw-top vial for detection (Detection Solutions).  
The analyte in Detection Solutions, Standards 1/2/3, pure Milli-Q water, pure PBS 1x 
buffer, pure octan-1-ol is detected in 5uL injections using LC-MS. SIM for the M+H mass (or half 
mass if it presents a stronger signal) to 1 or 2 decimal places for improved sensitivity.  
From the SIM data, obtain the area of analyte and tabulate for all samples. From the areas of 
the Milli-Q water and octan-1-ol standards, subtract the areas of the pure Milli-Q and pure octan-1-
ol for a baseline correction. Using the known concentrations of the standards and areas create a 
standard curve for each phase. From the areas of Detection Solutions, subtract the areas of the pure 
PBS 1x buffer and pure octan-1-ol respectively for a baseline correction. Using the standard curves 
and baseline corrected areas, calculate the concentration for each phase at each pH. The ratio of the 
analyte detected in the octan-1-ol phase to the aqueous phase at each pH is the D value. Using 
statistical software (PRISM), plot log D vs. pH and fit a sigmoidal equation to the data. The IC50 
value is the pKa of the compound. 
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Control Experiments  
LC-MS quantification  
 Usage of the shake-flask method in the literature has not typically relied on quantification 
with high resolution methods such as LC-MS. Since we are limited on the scale of analyte available, 
we needed a method that could quantify down to a resolution of 100 ng/mL. The rough estimation 
of the resolution of the LC-MS was done by quantifying serial dilutions of analyte used for standard 
curves in log D experiments. Based on known concentrations of the analyte, in SIM mode, the LC-
MS can indeed detect down to the order of 100ng/mL for compounds with tertiary amines. 
 
LC-MS benchmarking 
To test the viability of the LC-MS as a quantification method, initial experiments on a compound 
with a known log-D profile was performed, 1-aminobutane. Relative agreement with literature 
values48 and other methods suggest LC-MS can be used for future experiments. 
 
 
Sonication time 
 The protocol listed above mentions to sonicate the Test Solutions for 15 minutes. One 
might wonder if that is an adequate time to allow the compound to equilibrate. Sonication for 15 
minutes was compared against sonication for 10 hours. The results showed a small quantitative but 
not qualitative difference, suggesting the 15 minute time is adequate enough. 
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Centrifugation speed 
 The protocol listed above mentions to centrifuge the Test Solutions to de-mix the octanol 
and aqueous phases. One concern one might have is the larger mass of the analyte compounds may 
cause them to artificially accumulate in the denser aqueous phase during centrifugation. To prove 
this does not happen to an equal volume mixture of PBS 1x / octanol for the operating speeds of 
the centrifuge used (<3000 rpm), a fluorescent dye (FITC) was allowed to partition between the 
aqueous and octanol phase. Measuring the partition at various centrifugation speeds showed no 
change in the partition (data not shown). 
 
Partitioning occurs at equilibrium 
 The utility of the partitioning relies on the fact that it should be an equilibrium measurement. 
One way to prove that the measurements are made at equilibrium is by doing the measurement as 
mentioned in the protocols above. Then take the octanol and aqueous phase samples and re-mix 
them. Then proceed through the protocol again with this re-mixed Test Solution. If the 2nd 
measurement matches the initial measurement, that indicates the partition achieved the same 
thermal equilibrium state.  
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Nearly identical results for both batches indicate the partitioning achieves thermal equilibrium in 
both cases before the measurements are done. 
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Compound Verification 
NMR 
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DTDP assay 
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HPLC Traces and Corresponding LC-MS Traces and Mass Spectra 
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2-D Regression Plots between Parameters 
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Hill Slope 
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Log Dmax (log P) 
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Log Dmin 
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Comparing Models with AICc 
The R2 statistic is not appropriate for use when doing nonlinear regression. Instead, I will 
look at the Akaike information criteria (AIC)56,57. Specifically, we will look at AICc to correct for 
dealing with a relatively small sample size. The calculation for the difference between AIC for 2 
models is as follows, ∆AICäk]m	åAäk]m	æ = N ∙ ln Sum− of − squaresäk]m	åSum− of − squaresäk]m	æ + 2 ∙ ∆käk]m	åAäk]m	æ + 
 
where N is the sample size, and k is the number of parameters in the model. 
Roughly speaking, the value of this number estimates the relative quality of fit between 
models. It only provides a means of comparing the quality between models and does not give an 
absolute quality of the model. In other words, it can not indicate whether or not a model is the true 
underlying model that generated the data; rather, it serves as a way to pick the best model from a 
pool of potential model candidates. A more negative AICc value indicates a relatively better model. 
Grounded in principles from information theory, the AICc assesses goodness-of-fit while also 
comparing model complexity. With respect to the complexity, the criterion penalizes models for 
having too many parameters (overfitting). 
With the difference in AICc between two models calculated, one can then estimate the 
relative probability with which one model is better. That calculation is as follows, 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒	𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦	𝑜𝑓	𝑡ℎ𝑒	𝑏𝑒𝑡𝑡𝑒𝑟	𝑀𝑜𝑑𝑒𝑙 = 𝑒«.î∙∆æïðÁ1 + 𝑒«.î∙∆æïðÁ 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒	𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦	𝑜𝑓	𝑡ℎ𝑒	𝑤𝑜𝑟𝑠𝑒	𝑀𝑜𝑑𝑒𝑙= 1 − 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒	𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦	𝑜𝑓	𝑡ℎ𝑒	𝑏𝑒𝑡𝑡𝑒𝑟	𝑀𝑜𝑑𝑒𝑙 
 
The Boltzmann-like calculation for the probability reflects the idea that the minimization of AICc is 
analogous to maximizing the entropy in thermodynamics, highlighting again the information theory 
basis for this criterion.  
Using PRISM’s software, the different models for each oligoTEA in the library and their 
AICc are listed. For cases where 2 models had relatively similar AICc, a note was made on the 
probability ratio. In all the other cases, the best model has a probability of >99% than the 2nd best 
model. The best model(s) for each oligomer are highlighted in red. 
Oligomer 
AICc Value 
Model 1 
(2 parameters) 
AICc Value 
Model 2 
(3 parameters) 
AICc Value 
Model 3 
(4 parameters) 
Notes on comparing AICc values between models 
Acetyl-DTT-T (1 mer) -102.8 -100.1  Model 1 has a probability ratio of 3.82 over Model 2 (79% to 21%) 
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Acetyl-DTT-T (2 mer) -175 -193.1 -206.8  
Acetyl-DTT-T (3 mer) -31.27 -34.41 -31.4 
Model 2 has a probability ratio of 4.49 over Model 
3 (82% to 18%). Model 2 has a probability ratio of 
4.81 over Model 1 (83% to 17%) 
 
    
Acetyl-PDT-T (1 mer) -0.798 -83.82   
Acetyl-PDT-T (2 mer) 11.46 -110.8 -109.7 Model 2 has a probability ratio of 1.72 over Model 3 (63% to 37%) 
Acetyl-PDT-T (3 mer) 18.14 -67.86 -118.6  
 
    
Acetyl-PEG2-T (1 mer) -77.68 -155   
Acetyl-PEG2-T (2 mer) -31.39 -72.16 -84.34  
Acetyl-PEG2-T (3 mer) -12.07 -36.14 -34.52 Model 2 has probability ratio of 2.25 over Model 3 (69% to 31%) 
 
It is interesting to note that for only about half of the multi-mer oligomers Model 3 (which has the 
most parameters) is deemed the best model. Model 2 (the non-interacting MWC-like model) was 
objectively the best in several cases, edging out Model 3 for the DTT-T 3 mer, PDT-T 2 mer, and 
PEG2-T 3 mer. And Model 1 was even the best for the DTT-T 1mer. We see that the inclusion of 
cooperative effects is best for the 2 mer case in the DTT family, but when we increase length to the 
3 mer, the non-cooperative model is seen to be a better model. This was also the case in the PEG2 
family. Thus, the need to account for cooperative effects in a family of oligomers is not necessarily a 
linear function of its length. 
 
  
98 
 
Testing for Fitting Dependence on the Number of Protonation Sites 
If Model has Excessive Number of Sites 
 One might suspect that it is possible to incorrectly fit the 1mer data with models that are 
designed for a higher number of protonation sites (ex. models with 2- and 3- protonation sites). 
Note this is not the same as overfitting because adding more protonation sites does not increase the 
number of parameters in the model; rather, it changes the weights and multiplicities of the states. To 
test this, we compared fits of experimental data for the Acetyl-PDT-T (1mer) with MWC-type, non-
interacting models for 1-, 2-, and 3-protonation sites. The 1-protonation site model by definition is a 
non-interacting model, so the non-interacting models for the 2- and 3-protonate sites were used for 
a more direct comparison. 
  
Number of Protonation Sites in a 
MWC-type, Non-Interacting Model 
AICc 
1-Protonation Site -83.82 
2-Protonation Sites -62.12 
3-Protonation Sites -58.81 
 
When one performs the fit, the best fitting MWC-type, non-interacting model for the experimental 
1-mer data is actually the 1-protonation site model. This indicates that the model with the 
appropriate weights and multiplicities will best reflect the data, and that one cannot cheat the fitting 
by adding extra protonation sites into the model.  
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If Model Undercounts Number of Sites 
If we look at the opposite scenario where the number of protonation sites in the model is 
undercounted relative to the number of sites in the actual compound, we still come to the same 
conclusion. Here we show that for an Acetyl PDT-T (3mer), the best fitting model is the one that 
has weights and multiplicities corresponding to 3 sites. The 1- and 2-protonation site models do not 
fit the data as cleanly. 
 
Number of Protonation Sites in a 
MWC-type, Non-Interacting Model 
AICc 
1-Protonation Site -21.68 
2-Protonation Sites -54.31 
3-Protonation Sites -67.86 
 
Both of these examples illustrate that the Gibbs distribution correspond with accurate weights and 
multiplicities once you have defined the number of protonation states by properly enumerating the 
states. 
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Testing AICc on Overfitting of 1-mers 
To test if this AICc could account for overfitting, I took the 1 mers and tried to apply Model 
3 to them (i.e. a model with an interaction energy term). This physically doesn’t make sense because 
a 1 mer only has 1 site and thus doesn’t have any other site to physically interact with. But the 
addition of the parameter might still produce a good fit. Rather than having to rule out this model 
on physical intuition alone, I wanted to see if this criterion could do it for us objectively. Turns out it 
does it quite definitively. In all cases, the unphysical Model 3 that overfits the data is not deemed the 
best model by the AICc statistic. 
 
 AICc Value  
Oligomer Model 1 Model 2 Model 3 Notes on AICc comparison between models 
Acetyl-DTT-T (1 mer) -102.8 -100.1 -96.47 
Model 1 has a probability ratio of 3.82 over Model 2 (79% to 21%). 
Model 1 has a probability ratio of 23.32 over Model 3 (96% to 4%). 
Model 3 also doesn't have a proper physical interpretation 
Acetyl-PDT-T (1 mer) -0.798 -83.82 -80.2 Model 2 has a probability ratio of 6.11 over Model 3 (86% to 14%). Model 3 also doesn't have a proper physical interpretation 
Acetyl-PEG2-T (1 mer) -77.68 -155 -152.4 Model 2 has probability ratio of 3.71 over Model 3 (79% to 21%). Model 3 also doesn't have a proper physical interpretation 
